id	sid	tid	token	lemma	pos
dpc-5210	1	1	dermatology	dermatology	NOUN
dpc-5210	1	2	:	:	PUNCT
dpc-5210	1	3	practical	practical	ADJ
dpc-5210	1	4	and	and	CCONJ
dpc-5210	1	5	conceptual	conceptual	ADJ
dpc-5210	1	6	original	original	ADJ
dpc-5210	1	7	article	article	NOUN
dpc-5210	1	8	|	|	ADV
dpc-5210	1	9	dermatol	dermatol	ADJ
dpc-5210	1	10	pract	pract	NOUN
dpc-5210	1	11	concept	concept	NOUN
dpc-5210	1	12	.	.	PUNCT
dpc-5210	2	1	2025;15(4):5210	2025;15(4):5210	PROPN
dpc-5210	2	2	1	1	NUM
dpc-5210	2	3	stabilizing	stabilize	VERB
dpc-5210	2	4	progressive	progressive	ADJ
dpc-5210	2	5	vitiligo	vitiligo	VERB
dpc-5210	2	6	with	with	ADP
dpc-5210	2	7	systemic	systemic	ADJ
dpc-5210	2	8	treatment	treatment	NOUN
dpc-5210	2	9	:	:	PUNCT
dpc-5210	2	10	identifying	identify	VERB
dpc-5210	2	11	factors	factor	NOUN
dpc-5210	2	12	associated	associate	VERB
dpc-5210	2	13	with	with	ADP
dpc-5210	2	14	patients	patient	NOUN
dpc-5210	2	15	requiring	require	VERB
dpc-5210	2	16	prolonged	prolonged	ADJ
dpc-5210	2	17	treatment	treatment	NOUN
dpc-5210	2	18	duration	duration	NOUN
dpc-5210	2	19	ting	ting	PROPN
dpc-5210	2	20	-	-	PUNCT
dpc-5210	2	21	ting	ting	PROPN
dpc-5210	2	22	yang1,2	yang1,2	PROPN
dpc-5210	2	23	,	,	PUNCT
dpc-5210	2	24	cheng	cheng	PROPN
dpc-5210	2	25	-	-	PUNCT
dpc-5210	2	26	che	che	PROPN
dpc-5210	2	27	e.	e.	PROPN
dpc-5210	2	28	lan2,3	lan2,3	PROPN
dpc-5210	2	29	1	1	NUM
dpc-5210	2	30	department	department	NOUN
dpc-5210	2	31	of	of	ADP
dpc-5210	2	32	dermatology	dermatology	NOUN
dpc-5210	2	33	,	,	PUNCT
dpc-5210	2	34	kaohsiung	kaohsiung	PROPN
dpc-5210	2	35	medical	medical	PROPN
dpc-5210	2	36	university	university	PROPN
dpc-5210	2	37	gangshan	gangshan	PROPN
dpc-5210	2	38	hospital	hospital	PROPN
dpc-5210	2	39	,	,	PUNCT
dpc-5210	2	40	kaohsiung	kaohsiung	PROPN
dpc-5210	2	41	,	,	PUNCT
dpc-5210	2	42	taiwan	taiwan	PROPN
dpc-5210	2	43	2	2	NUM
dpc-5210	2	44	department	department	NOUN
dpc-5210	2	45	of	of	ADP
dpc-5210	2	46	dermatology	dermatology	NOUN
dpc-5210	2	47	,	,	PUNCT
dpc-5210	2	48	kaohsiung	kaohsiung	PROPN
dpc-5210	2	49	medical	medical	PROPN
dpc-5210	2	50	university	university	PROPN
dpc-5210	2	51	hospital	hospital	NOUN
dpc-5210	2	52	,	,	PUNCT
dpc-5210	2	53	kaohsiung	kaohsiung	PROPN
dpc-5210	2	54	medical	medical	PROPN
dpc-5210	2	55	university	university	PROPN
dpc-5210	2	56	,	,	PUNCT
dpc-5210	2	57	kaohsiung	kaohsiung	PROPN
dpc-5210	2	58	,	,	PUNCT
dpc-5210	2	59	taiwan	taiwan	PROPN
dpc-5210	2	60	3	3	NUM
dpc-5210	2	61	department	department	PROPN
dpc-5210	2	62	of	of	ADP
dpc-5210	2	63	dermatology	dermatology	NOUN
dpc-5210	2	64	,	,	PUNCT
dpc-5210	2	65	college	college	NOUN
dpc-5210	2	66	of	of	ADP
dpc-5210	2	67	medicine	medicine	NOUN
dpc-5210	2	68	,	,	PUNCT
dpc-5210	2	69	kaohsiung	kaohsiung	PROPN
dpc-5210	2	70	medical	medical	PROPN
dpc-5210	2	71	university	university	PROPN
dpc-5210	2	72	,	,	PUNCT
dpc-5210	2	73	kaohsiung	kaohsiung	PROPN
dpc-5210	2	74	,	,	PUNCT
dpc-5210	2	75	taiwan	taiwan	PROPN
dpc-5210	2	76	key	key	ADJ
dpc-5210	2	77	words	word	NOUN
dpc-5210	2	78	:	:	PUNCT
dpc-5210	2	79	active	active	ADJ
dpc-5210	2	80	vitiligo	vitiligo	NOUN
dpc-5210	2	81	,	,	PUNCT
dpc-5210	2	82	immunosuppression	immunosuppression	NOUN
dpc-5210	2	83	medications	medication	NOUN
dpc-5210	2	84	,	,	PUNCT
dpc-5210	2	85	repigmentation	repigmentation	NOUN
dpc-5210	2	86	citation	citation	NOUN
dpc-5210	2	87	:	:	PUNCT
dpc-5210	2	88	yang	yang	PROPN
dpc-5210	2	89	tt	tt	PROPN
dpc-5210	2	90	,	,	PUNCT
dpc-5210	2	91	lan	lan	PROPN
dpc-5210	2	92	cc	cc	PROPN
dpc-5210	2	93	.	.	PROPN
dpc-5210	2	94	stabilizing	stabilize	VERB
dpc-5210	2	95	progressive	progressive	ADJ
dpc-5210	2	96	vitiligo	vitiligo	VERB
dpc-5210	2	97	with	with	ADP
dpc-5210	2	98	systemic	systemic	ADJ
dpc-5210	2	99	treatment	treatment	NOUN
dpc-5210	2	100	:	:	PUNCT
dpc-5210	2	101	identifying	identify	VERB
dpc-5210	2	102	factors	factor	NOUN
dpc-5210	2	103	associated	associate	VERB
dpc-5210	2	104	with	with	ADP
dpc-5210	2	105	patients	patient	NOUN
dpc-5210	2	106	requiring	require	VERB
dpc-5210	2	107	prolonged	prolonged	ADJ
dpc-5210	2	108	treatment	treatment	NOUN
dpc-5210	2	109	duration	duration	NOUN
dpc-5210	2	110	.	.	PUNCT
dpc-5210	3	1	dermatol	dermatol	NOUN
dpc-5210	3	2	pract	pract	PROPN
dpc-5210	3	3	concept	concept	NOUN
dpc-5210	3	4	.	.	PUNCT
dpc-5210	4	1	2025;15(4):5210	2025;15(4):5210	NOUN
dpc-5210	4	2	.	.	PUNCT
dpc-5210	5	1	doi	doi	PROPN
dpc-5210	5	2	:	:	PUNCT
dpc-5210	5	3	https://doi.org/10.5826/dpc.1504a5210	https://doi.org/10.5826/dpc.1504a5210	PROPN
dpc-5210	5	4	accepted	accept	VERB
dpc-5210	5	5	:	:	PUNCT
dpc-5210	5	6	march	march	PROPN
dpc-5210	5	7	6	6	NUM
dpc-5210	5	8	,	,	PUNCT
dpc-5210	5	9	2025	2025	NUM
dpc-5210	5	10	;	;	PUNCT
dpc-5210	5	11	published	publish	VERB
dpc-5210	5	12	:	:	PUNCT
dpc-5210	6	1	october	october	PROPN
dpc-5210	6	2	2025	2025	NUM
dpc-5210	6	3	copyright	copyright	NOUN
dpc-5210	6	4	:	:	PUNCT
dpc-5210	6	5	©	©	PROPN
dpc-5210	6	6	2025	2025	NUM
dpc-5210	6	7	yang	yang	PROPN
dpc-5210	6	8	et	et	PROPN
dpc-5210	6	9	al	al	PROPN
dpc-5210	6	10	.	.	PUNCT
dpc-5210	7	1	this	this	PRON
dpc-5210	7	2	is	be	AUX
dpc-5210	7	3	an	an	DET
dpc-5210	7	4	open	open	ADJ
dpc-5210	7	5	-	-	PUNCT
dpc-5210	7	6	access	access	NOUN
dpc-5210	7	7	article	article	NOUN
dpc-5210	7	8	distributed	distribute	VERB
dpc-5210	7	9	under	under	ADP
dpc-5210	7	10	the	the	DET
dpc-5210	7	11	terms	term	NOUN
dpc-5210	7	12	of	of	ADP
dpc-5210	7	13	the	the	DET
dpc-5210	7	14	creative	creative	ADJ
dpc-5210	7	15	commons	common	NOUN
dpc-5210	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5210	7	17	license	license	NOUN
dpc-5210	7	18	(	(	PUNCT
dpc-5210	7	19	by	by	ADP
dpc-5210	7	20	-	-	PUNCT
dpc-5210	7	21	nc-4.0	nc-4.0	NOUN
dpc-5210	7	22	)	)	PUNCT
dpc-5210	7	23	,	,	PUNCT
dpc-5210	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5210	7	25	,	,	PUNCT
dpc-5210	7	26	which	which	PRON
dpc-5210	7	27	permits	permit	VERB
dpc-5210	7	28	unrestricted	unrestricted	ADJ
dpc-5210	7	29	noncommercial	noncommercial	ADJ
dpc-5210	7	30	use	use	NOUN
dpc-5210	7	31	,	,	PUNCT
dpc-5210	7	32	distribution	distribution	NOUN
dpc-5210	7	33	,	,	PUNCT
dpc-5210	7	34	and	and	CCONJ
dpc-5210	7	35	reproduction	reproduction	NOUN
dpc-5210	7	36	in	in	ADP
dpc-5210	7	37	any	any	DET
dpc-5210	7	38	medium	medium	NOUN
dpc-5210	7	39	,	,	PUNCT
dpc-5210	7	40	provided	provide	VERB
dpc-5210	7	41	the	the	DET
dpc-5210	7	42	original	original	ADJ
dpc-5210	7	43	authors	author	NOUN
dpc-5210	7	44	and	and	CCONJ
dpc-5210	7	45	source	source	NOUN
dpc-5210	7	46	are	be	AUX
dpc-5210	7	47	credited	credit	VERB
dpc-5210	7	48	.	.	PUNCT
dpc-5210	8	1	funding	funding	NOUN
dpc-5210	8	2	:	:	PUNCT
dpc-5210	8	3	none	none	NOUN
dpc-5210	8	4	.	.	PUNCT
dpc-5210	9	1	competing	compete	VERB
dpc-5210	9	2	interests	interest	NOUN
dpc-5210	9	3	:	:	PUNCT
dpc-5210	9	4	none	none	NOUN
dpc-5210	9	5	.	.	PUNCT
dpc-5210	10	1	authorship	authorship	NOUN
dpc-5210	10	2	:	:	PUNCT
dpc-5210	10	3	all	all	DET
dpc-5210	10	4	authors	author	NOUN
dpc-5210	10	5	have	have	AUX
dpc-5210	10	6	contributed	contribute	VERB
dpc-5210	10	7	significantly	significantly	ADV
dpc-5210	10	8	to	to	ADP
dpc-5210	10	9	this	this	DET
dpc-5210	10	10	publication	publication	NOUN
dpc-5210	10	11	.	.	PUNCT
dpc-5210	11	1	corresponding	correspond	VERB
dpc-5210	11	2	author	author	NOUN
dpc-5210	11	3	:	:	PUNCT
dpc-5210	11	4	cheng	cheng	PROPN
dpc-5210	11	5	-	-	PUNCT
dpc-5210	11	6	che	che	PROPN
dpc-5210	11	7	e.	e.	PROPN
dpc-5210	11	8	lan	lan	PROPN
dpc-5210	11	9	,	,	PUNCT
dpc-5210	11	10	professor	professor	NOUN
dpc-5210	11	11	,	,	PUNCT
dpc-5210	11	12	100	100	NUM
dpc-5210	11	13	shih	shih	NOUN
dpc-5210	11	14	-	-	PUNCT
dpc-5210	11	15	chuan	chuan	PROPN
dpc-5210	11	16	1st	1st	PROPN
dpc-5210	11	17	rd	rd	PROPN
dpc-5210	11	18	,	,	PUNCT
dpc-5210	11	19	kaohsiung	kaohsiung	PROPN
dpc-5210	11	20	,	,	PUNCT
dpc-5210	11	21	taiwan	taiwan	PROPN
dpc-5210	11	22	;	;	PUNCT
dpc-5210	11	23	department	department	NOUN
dpc-5210	11	24	of	of	ADP
dpc-5210	11	25	dermatology	dermatology	NOUN
dpc-5210	11	26	,	,	PUNCT
dpc-5210	11	27	kaohsiung	kaohsiung	PROPN
dpc-5210	11	28	medical	medical	PROPN
dpc-5210	11	29	university	university	PROPN
dpc-5210	11	30	hospital	hospital	NOUN
dpc-5210	11	31	,	,	PUNCT
dpc-5210	11	32	kaohsiung	kaohsiung	PROPN
dpc-5210	11	33	medical	medical	PROPN
dpc-5210	11	34	university	university	PROPN
dpc-5210	11	35	.	.	PUNCT
dpc-5210	12	1	orcid	orcid	NOUN
dpc-5210	13	1	i	i	PRON
dpc-5210	13	2	d	d	NOUN
dpc-5210	13	3	:	:	PUNCT
dpc-5210	13	4	0000	0000	NUM
dpc-5210	13	5	-	-	PUNCT
dpc-5210	13	6	0003	0003	NUM
dpc-5210	13	7	-	-	PUNCT
dpc-5210	13	8	4654	4654	NUM
dpc-5210	13	9	-	-	PUNCT
dpc-5210	13	10	118x	118x	PROPN
dpc-5210	13	11	.	.	PUNCT
dpc-5210	14	1	e	e	X
dpc-5210	14	2	-	-	NOUN
dpc-5210	14	3	mail	mail	NOUN
dpc-5210	14	4	:	:	PUNCT
dpc-5210	14	5	laneric@cc.kmu.edu.tw	laneric@cc.kmu.edu.tw	NOUN
dpc-5210	14	6	introduction	introduction	NOUN
dpc-5210	14	7	:	:	PUNCT
dpc-5210	14	8	patients	patient	NOUN
dpc-5210	14	9	with	with	ADP
dpc-5210	14	10	active	active	ADJ
dpc-5210	14	11	vitiligo	vitiligo	NOUN
dpc-5210	14	12	are	be	AUX
dpc-5210	14	13	treated	treat	VERB
dpc-5210	14	14	with	with	ADP
dpc-5210	14	15	systemic	systemic	ADJ
dpc-5210	14	16	immunosuppressants	immunosuppressant	NOUN
dpc-5210	14	17	to	to	PART
dpc-5210	14	18	halt	halt	VERB
dpc-5210	14	19	disease	disease	NOUN
dpc-5210	14	20	progression	progression	NOUN
dpc-5210	14	21	.	.	PUNCT
dpc-5210	15	1	however	however	ADV
dpc-5210	15	2	,	,	PUNCT
dpc-5210	15	3	clinical	clinical	ADJ
dpc-5210	15	4	features	feature	NOUN
dpc-5210	15	5	associated	associate	VERB
dpc-5210	15	6	with	with	ADP
dpc-5210	15	7	patients	patient	NOUN
dpc-5210	15	8	whose	whose	DET
dpc-5210	15	9	condition	condition	NOUN
dpc-5210	15	10	is	be	AUX
dpc-5210	15	11	more	more	ADV
dpc-5210	15	12	difficult	difficult	ADJ
dpc-5210	15	13	to	to	PART
dpc-5210	15	14	control	control	VERB
dpc-5210	15	15	are	be	AUX
dpc-5210	15	16	unknown	unknown	ADJ
dpc-5210	15	17	.	.	PUNCT
dpc-5210	16	1	objective	objective	NOUN
dpc-5210	16	2	:	:	PUNCT
dpc-5210	16	3	this	this	DET
dpc-5210	16	4	study	study	NOUN
dpc-5210	16	5	aimed	aim	VERB
dpc-5210	16	6	to	to	PART
dpc-5210	16	7	identify	identify	VERB
dpc-5210	16	8	the	the	DET
dpc-5210	16	9	clinical	clinical	ADJ
dpc-5210	16	10	features	feature	NOUN
dpc-5210	16	11	of	of	ADP
dpc-5210	16	12	patients	patient	NOUN
dpc-5210	16	13	requiring	require	VERB
dpc-5210	16	14	extended	extended	ADJ
dpc-5210	16	15	periods	period	NOUN
dpc-5210	16	16	of	of	ADP
dpc-5210	16	17	systemic	systemic	ADJ
dpc-5210	16	18	immunosuppressants	immunosuppressant	NOUN
dpc-5210	16	19	and	and	CCONJ
dpc-5210	16	20	the	the	DET
dpc-5210	16	21	real	real	ADJ
dpc-5210	16	22	-	-	PUNCT
dpc-5210	16	23	world	world	NOUN
dpc-5210	16	24	clinical	clinical	ADJ
dpc-5210	16	25	course	course	NOUN
dpc-5210	16	26	of	of	ADP
dpc-5210	16	27	active	active	ADJ
dpc-5210	16	28	vitiligo	vitiligo	NOUN
dpc-5210	16	29	patients	patient	NOUN
dpc-5210	16	30	receiving	receive	VERB
dpc-5210	16	31	systemic	systemic	ADJ
dpc-5210	16	32	treatments	treatment	NOUN
dpc-5210	16	33	.	.	PUNCT
dpc-5210	17	1	methods	method	NOUN
dpc-5210	17	2	:	:	PUNCT
dpc-5210	17	3	this	this	PRON
dpc-5210	17	4	was	be	AUX
dpc-5210	17	5	a	a	DET
dpc-5210	17	6	single	single	ADJ
dpc-5210	17	7	-	-	PUNCT
dpc-5210	17	8	center	center	NOUN
dpc-5210	17	9	retrospective	retrospective	ADJ
dpc-5210	17	10	study	study	NOUN
dpc-5210	17	11	.	.	PUNCT
dpc-5210	18	1	records	record	NOUN
dpc-5210	18	2	of	of	ADP
dpc-5210	18	3	actively	actively	ADV
dpc-5210	18	4	progressing	progress	VERB
dpc-5210	18	5	vitiligo	vitiligo	ADJ
dpc-5210	18	6	patients	patient	NOUN
dpc-5210	18	7	from	from	ADP
dpc-5210	18	8	september	september	PROPN
dpc-5210	18	9	2017	2017	NUM
dpc-5210	18	10	to	to	ADP
dpc-5210	18	11	august	august	PROPN
dpc-5210	18	12	2023	2023	NUM
dpc-5210	18	13	were	be	AUX
dpc-5210	18	14	reviewed	review	VERB
dpc-5210	18	15	.	.	PUNCT
dpc-5210	19	1	results	result	NOUN
dpc-5210	19	2	:	:	PUNCT
dpc-5210	19	3	one	one	NUM
dpc-5210	19	4	hundred	hundred	NUM
dpc-5210	19	5	and	and	CCONJ
dpc-5210	19	6	fifty	fifty	NUM
dpc-5210	19	7	-	-	PUNCT
dpc-5210	19	8	nine	nine	NUM
dpc-5210	19	9	patients	patient	NOUN
dpc-5210	19	10	with	with	ADP
dpc-5210	19	11	non	non	ADJ
dpc-5210	19	12	-	-	ADJ
dpc-5210	19	13	segmental	segmental	ADJ
dpc-5210	19	14	actively	actively	ADV
dpc-5210	19	15	progressing	progress	VERB
dpc-5210	19	16	vitiligo	vitiligo	NOUN
dpc-5210	19	17	were	be	AUX
dpc-5210	19	18	enrolled	enrol	VERB
dpc-5210	19	19	.	.	PUNCT
dpc-5210	20	1	in	in	ADP
dpc-5210	20	2	the	the	DET
dpc-5210	20	3	six	six	NUM
dpc-5210	20	4	-	-	PUNCT
dpc-5210	20	5	month	month	NOUN
dpc-5210	20	6	follow	follow	NOUN
dpc-5210	20	7	-	-	PUNCT
dpc-5210	20	8	up	up	NOUN
dpc-5210	20	9	period	period	NOUN
dpc-5210	20	10	,	,	PUNCT
dpc-5210	20	11	101	101	NUM
dpc-5210	20	12	(	(	PUNCT
dpc-5210	20	13	63.52	63.52	NUM
dpc-5210	20	14	%	%	NOUN
dpc-5210	20	15	)	)	PUNCT
dpc-5210	20	16	patients	patient	NOUN
dpc-5210	20	17	required	require	VERB
dpc-5210	20	18	oral	oral	ADJ
dpc-5210	20	19	systemic	systemic	ADJ
dpc-5210	20	20	immunosuppressants	immunosuppressant	NOUN
dpc-5210	20	21	for	for	ADP
dpc-5210	20	22	≤	≤	NUM
dpc-5210	20	23	16	16	NUM
dpc-5210	20	24	weeks	week	NOUN
dpc-5210	20	25	without	without	ADP
dpc-5210	20	26	reactivation	reactivation	NOUN
dpc-5210	20	27	(	(	PUNCT
dpc-5210	20	28	group	group	NOUN
dpc-5210	20	29	1	1	NUM
dpc-5210	20	30	)	)	PUNCT
dpc-5210	20	31	,	,	PUNCT
dpc-5210	20	32	51	51	NUM
dpc-5210	20	33	(	(	PUNCT
dpc-5210	20	34	32.08	32.08	NUM
dpc-5210	20	35	%	%	NOUN
dpc-5210	20	36	)	)	PUNCT
dpc-5210	20	37	patients	patient	NOUN
dpc-5210	20	38	required	require	VERB
dpc-5210	20	39	continuous	continuous	ADJ
dpc-5210	20	40	systemic	systemic	ADJ
dpc-5210	20	41	immunosuppressants	immunosuppressant	NOUN
dpc-5210	20	42	for	for	ADP
dpc-5210	20	43	more	more	ADJ
dpc-5210	20	44	than	than	ADP
dpc-5210	20	45	16	16	NUM
dpc-5210	20	46	weeks	week	NOUN
dpc-5210	20	47	to	to	PART
dpc-5210	20	48	achieve	achieve	VERB
dpc-5210	20	49	disease	disease	NOUN
dpc-5210	20	50	stabilization	stabilization	NOUN
dpc-5210	20	51	(	(	PUNCT
dpc-5210	20	52	group	group	NOUN
dpc-5210	20	53	2	2	NUM
dpc-5210	20	54	)	)	PUNCT
dpc-5210	20	55	,	,	PUNCT
dpc-5210	20	56	and	and	CCONJ
dpc-5210	20	57	seven	seven	NUM
dpc-5210	20	58	(	(	PUNCT
dpc-5210	20	59	4.4	4.4	NUM
dpc-5210	20	60	%	%	NOUN
dpc-5210	20	61	)	)	PUNCT
dpc-5210	20	62	patients	patient	NOUN
dpc-5210	20	63	achieved	achieve	VERB
dpc-5210	20	64	disease	disease	NOUN
dpc-5210	20	65	stabilization	stabilization	NOUN
dpc-5210	20	66	≤16	≤16	NOUN
dpc-5210	20	67	weeks	week	NOUN
dpc-5210	20	68	of	of	ADP
dpc-5210	20	69	oral	oral	ADJ
dpc-5210	20	70	immunosuppressants	immunosuppressant	NOUN
dpc-5210	20	71	but	but	CCONJ
dpc-5210	20	72	recurred	recur	VERB
dpc-5210	20	73	within	within	ADP
dpc-5210	20	74	nine	nine	NUM
dpc-5210	20	75	months	month	NOUN
dpc-5210	20	76	after	after	ADP
dpc-5210	20	77	stabilization	stabilization	NOUN
dpc-5210	20	78	(	(	PUNCT
dpc-5210	20	79	group	group	NOUN
dpc-5210	20	80	3	3	NUM
dpc-5210	20	81	)	)	PUNCT
dpc-5210	20	82	.	.	PUNCT
dpc-5210	21	1	patients	patient	NOUN
dpc-5210	21	2	in	in	ADP
dpc-5210	21	3	group	group	NOUN
dpc-5210	21	4	2	2	NUM
dpc-5210	21	5	were	be	AUX
dpc-5210	21	6	significantly	significantly	ADV
dpc-5210	21	7	younger	young	ADJ
dpc-5210	21	8	(	(	PUNCT
dpc-5210	21	9	39.69±11.51	39.69±11.51	NOUN
dpc-5210	21	10	vs.	vs.	ADP
dpc-5210	21	11	46.47±14.91	46.47±14.91	NOUN
dpc-5210	21	12	years	year	NOUN
dpc-5210	21	13	old	old	ADJ
dpc-5210	21	14	;	;	PUNCT
dpc-5210	21	15	p=0.013	p=0.013	X
dpc-5210	21	16	)	)	PUNCT
dpc-5210	21	17	and	and	CCONJ
dpc-5210	21	18	had	have	VERB
dpc-5210	21	19	a	a	DET
dpc-5210	21	20	lower	low	ADJ
dpc-5210	21	21	proportion	proportion	NOUN
dpc-5210	21	22	of	of	ADP
dpc-5210	21	23	facial	facial	ADJ
dpc-5210	21	24	involvement	involvement	NOUN
dpc-5210	21	25	(	(	PUNCT
dpc-5210	21	26	56.86	56.86	NUM
dpc-5210	21	27	%	%	NOUN
dpc-5210	21	28	vs.	vs.	ADP
dpc-5210	21	29	76.24	76.24	NUM
dpc-5210	21	30	%	%	NOUN
dpc-5210	21	31	;	;	PUNCT
dpc-5210	21	32	p=0.016	p=0.016	X
dpc-5210	21	33	)	)	PUNCT
dpc-5210	21	34	compared	compare	VERB
dpc-5210	21	35	to	to	ADP
dpc-5210	21	36	group	group	NOUN
dpc-5210	21	37	1	1	NUM
dpc-5210	21	38	.	.	PUNCT
dpc-5210	21	39	similarly	similarly	ADV
dpc-5210	21	40	,	,	PUNCT
dpc-5210	21	41	both	both	DET
dpc-5210	21	42	age	age	NOUN
dpc-5210	21	43	(	(	PUNCT
dpc-5210	21	44	odds	odd	NOUN
dpc-5210	21	45	ratio	ratio	NOUN
dpc-5210	21	46	abstract	abstract	ADJ
dpc-5210	21	47	2	2	NUM
dpc-5210	21	48	original	original	ADJ
dpc-5210	21	49	article	article	NOUN
dpc-5210	21	50	|	|	ADV
dpc-5210	21	51	dermatol	dermatol	ADJ
dpc-5210	21	52	pract	pract	NOUN
dpc-5210	21	53	concept	concept	NOUN
dpc-5210	21	54	.	.	PUNCT
dpc-5210	22	1	2025;15(4):5210	2025;15(4):5210	NUM
dpc-5210	22	2	introduction	introduction	NOUN
dpc-5210	22	3	vitiligo	vitiligo	NOUN
dpc-5210	22	4	affects	affect	VERB
dpc-5210	22	5	approximately	approximately	ADV
dpc-5210	22	6	1	1	NUM
dpc-5210	22	7	%	%	NOUN
dpc-5210	22	8	of	of	ADP
dpc-5210	22	9	the	the	DET
dpc-5210	22	10	world	world	NOUN
dpc-5210	22	11	’s	’s	PART
dpc-5210	22	12	population	population	NOUN
dpc-5210	22	13	and	and	CCONJ
dpc-5210	22	14	significantly	significantly	ADV
dpc-5210	22	15	impacts	impact	VERB
dpc-5210	22	16	patients	patient	NOUN
dpc-5210	22	17	’	'	PUNCT
dpc-5210	22	18	quality	quality	NOUN
dpc-5210	22	19	of	of	ADP
dpc-5210	22	20	life	life	NOUN
dpc-5210	22	21	[	[	X
dpc-5210	22	22	1,2	1,2	NUM
dpc-5210	22	23	]	]	PUNCT
dpc-5210	22	24	.	.	PUNCT
dpc-5210	23	1	currently	currently	ADV
dpc-5210	23	2	,	,	PUNCT
dpc-5210	23	3	treatment	treatment	NOUN
dpc-5210	23	4	of	of	ADP
dpc-5210	23	5	vitiligo	vitiligo	NOUN
dpc-5210	23	6	includes	include	VERB
dpc-5210	23	7	topical	topical	ADJ
dpc-5210	23	8	and/or	and/or	CCONJ
dpc-5210	23	9	oral	oral	ADJ
dpc-5210	23	10	immunosuppressants	immunosuppressant	NOUN
dpc-5210	23	11	in	in	ADP
dpc-5210	23	12	combination	combination	NOUN
dpc-5210	23	13	with	with	ADP
dpc-5210	23	14	phototherapy	phototherapy	NOUN
dpc-5210	23	15	[	[	X
dpc-5210	23	16	3,4	3,4	NUM
dpc-5210	23	17	]	]	PUNCT
dpc-5210	23	18	.	.	PUNCT
dpc-5210	24	1	for	for	ADP
dpc-5210	24	2	chronic	chronic	ADJ
dpc-5210	24	3	stable	stable	ADJ
dpc-5210	24	4	vitiligo	vitiligo	NOUN
dpc-5210	24	5	,	,	PUNCT
dpc-5210	24	6	topical	topical	ADJ
dpc-5210	24	7	corticosteroids	corticosteroid	NOUN
dpc-5210	24	8	or	or	CCONJ
dpc-5210	24	9	topical	topical	ADJ
dpc-5210	24	10	calcineurin	calcineurin	NOUN
dpc-5210	24	11	inhibitors	inhibitor	NOUN
dpc-5210	24	12	in	in	ADP
dpc-5210	24	13	combination	combination	NOUN
dpc-5210	24	14	with	with	ADP
dpc-5210	24	15	phototherapy	phototherapy	NOUN
dpc-5210	24	16	are	be	AUX
dpc-5210	24	17	suggested	suggest	VERB
dpc-5210	24	18	[	[	PUNCT
dpc-5210	24	19	3,4	3,4	NUM
dpc-5210	24	20	]	]	PUNCT
dpc-5210	24	21	.	.	PUNCT
dpc-5210	25	1	for	for	ADP
dpc-5210	25	2	patients	patient	NOUN
dpc-5210	25	3	with	with	ADP
dpc-5210	25	4	rapidly	rapidly	ADV
dpc-5210	25	5	progressing	progress	VERB
dpc-5210	25	6	disease	disease	NOUN
dpc-5210	25	7	,	,	PUNCT
dpc-5210	25	8	however	however	ADV
dpc-5210	25	9	,	,	PUNCT
dpc-5210	25	10	systemic	systemic	ADJ
dpc-5210	25	11	oral	oral	ADJ
dpc-5210	25	12	immunosuppressants	immunosuppressant	NOUN
dpc-5210	25	13	for	for	ADP
dpc-5210	25	14	three	three	NUM
dpc-5210	25	15	to	to	PART
dpc-5210	25	16	six	six	NUM
dpc-5210	25	17	months	month	NOUN
dpc-5210	25	18	are	be	AUX
dpc-5210	25	19	recommended	recommend	VERB
dpc-5210	25	20	to	to	PART
dpc-5210	25	21	suppress	suppress	VERB
dpc-5210	25	22	immunemediated	immunemediate	VERB
dpc-5210	25	23	destruction	destruction	NOUN
dpc-5210	25	24	of	of	ADP
dpc-5210	25	25	melanocytes	melanocyte	NOUN
dpc-5210	25	26	in	in	ADP
dpc-5210	25	27	addition	addition	NOUN
dpc-5210	25	28	to	to	ADP
dpc-5210	25	29	phototherapy	phototherapy	NOUN
dpc-5210	25	30	[	[	X
dpc-5210	25	31	3,4	3,4	NUM
dpc-5210	25	32	]	]	PUNCT
dpc-5210	25	33	.	.	PUNCT
dpc-5210	26	1	various	various	ADJ
dpc-5210	26	2	regimens	regimen	NOUN
dpc-5210	26	3	of	of	ADP
dpc-5210	26	4	systemic	systemic	ADJ
dpc-5210	26	5	immunosuppressants	immunosuppressant	NOUN
dpc-5210	26	6	have	have	AUX
dpc-5210	26	7	been	be	AUX
dpc-5210	26	8	proposed	propose	VERB
dpc-5210	26	9	.	.	PUNCT
dpc-5210	27	1	oral	oral	ADJ
dpc-5210	27	2	mini	mini	ADJ
dpc-5210	27	3	-	-	ADJ
dpc-5210	27	4	pulse	pulse	ADJ
dpc-5210	27	5	corticosteroid	corticosteroid	NOUN
dpc-5210	27	6	therapy	therapy	NOUN
dpc-5210	27	7	with	with	ADP
dpc-5210	27	8	doses	dose	NOUN
dpc-5210	27	9	equivalent	equivalent	ADJ
dpc-5210	27	10	to	to	ADP
dpc-5210	27	11	2–10	2–10	NOUN
dpc-5210	27	12	mg	mg	PROPN
dpc-5210	27	13	dexamethasone/	dexamethasone/	PROPN
dpc-5210	27	14	betamethasone	betamethasone	PROPN
dpc-5210	27	15	twice	twice	ADV
dpc-5210	27	16	weekly	weekly	ADV
dpc-5210	27	17	on	on	ADP
dpc-5210	27	18	two	two	NUM
dpc-5210	27	19	consecutive	consecutive	ADJ
dpc-5210	27	20	days	day	NOUN
dpc-5210	27	21	has	have	AUX
dpc-5210	27	22	been	be	AUX
dpc-5210	27	23	shown	show	VERB
dpc-5210	27	24	to	to	PART
dpc-5210	27	25	halt	halt	VERB
dpc-5210	27	26	disease	disease	NOUN
dpc-5210	27	27	progression	progression	NOUN
dpc-5210	27	28	while	while	SCONJ
dpc-5210	27	29	minimizing	minimize	VERB
dpc-5210	27	30	steroid	steroid	NOUN
dpc-5210	27	31	-	-	PUNCT
dpc-5210	27	32	induced	induce	VERB
dpc-5210	27	33	side	side	NOUN
dpc-5210	27	34	effects	effect	NOUN
dpc-5210	27	35	[	[	X
dpc-5210	27	36	3	3	NUM
dpc-5210	27	37	-	-	SYM
dpc-5210	27	38	7	7	NUM
dpc-5210	27	39	]	]	PUNCT
dpc-5210	27	40	.	.	PUNCT
dpc-5210	28	1	low	low	ADJ
dpc-5210	28	2	-	-	PUNCT
dpc-5210	28	3	dose	dose	NOUN
dpc-5210	28	4	methotrexate	methotrexate	NOUN
dpc-5210	28	5	,	,	PUNCT
dpc-5210	28	6	ranging	range	VERB
dpc-5210	28	7	from	from	ADP
dpc-5210	28	8	7.5	7.5	NUM
dpc-5210	28	9	to	to	PART
dpc-5210	28	10	25	25	NUM
dpc-5210	28	11	mg	mg	NOUN
dpc-5210	28	12	weekly	weekly	NOUN
dpc-5210	28	13	,	,	PUNCT
dpc-5210	28	14	is	be	AUX
dpc-5210	28	15	also	also	ADV
dpc-5210	28	16	effective	effective	ADJ
dpc-5210	28	17	[	[	PUNCT
dpc-5210	28	18	3,5,7	3,5,7	NUM
dpc-5210	28	19	-	-	SYM
dpc-5210	28	20	9	9	NUM
dpc-5210	28	21	]	]	PUNCT
dpc-5210	28	22	.	.	PUNCT
dpc-5210	29	1	however	however	ADV
dpc-5210	29	2	,	,	PUNCT
dpc-5210	29	3	the	the	DET
dpc-5210	29	4	required	require	VERB
dpc-5210	29	5	length	length	NOUN
dpc-5210	29	6	of	of	ADP
dpc-5210	29	7	treatment	treatment	NOUN
dpc-5210	29	8	varies	vary	VERB
dpc-5210	29	9	among	among	ADP
dpc-5210	29	10	patients	patient	NOUN
dpc-5210	29	11	,	,	PUNCT
dpc-5210	29	12	and	and	CCONJ
dpc-5210	29	13	some	some	DET
dpc-5210	29	14	patients	patient	NOUN
dpc-5210	29	15	experience	experience	VERB
dpc-5210	29	16	relapsing	relapse	VERB
dpc-5210	29	17	disease	disease	NOUN
dpc-5210	29	18	,	,	PUNCT
dpc-5210	29	19	making	make	VERB
dpc-5210	29	20	multiple	multiple	ADJ
dpc-5210	29	21	courses	course	NOUN
dpc-5210	29	22	of	of	ADP
dpc-5210	29	23	systemic	systemic	ADJ
dpc-5210	29	24	treatments	treatment	NOUN
dpc-5210	29	25	necessary	necessary	ADJ
dpc-5210	29	26	[	[	X
dpc-5210	29	27	6,10	6,10	X
dpc-5210	29	28	]	]	PUNCT
dpc-5210	29	29	.	.	PUNCT
dpc-5210	30	1	until	until	ADP
dpc-5210	30	2	now	now	ADV
dpc-5210	30	3	,	,	PUNCT
dpc-5210	30	4	there	there	PRON
dpc-5210	30	5	have	have	AUX
dpc-5210	30	6	been	be	AUX
dpc-5210	30	7	no	no	DET
dpc-5210	30	8	known	know	VERB
dpc-5210	30	9	clinical	clinical	ADJ
dpc-5210	30	10	features	feature	NOUN
dpc-5210	30	11	associated	associate	VERB
dpc-5210	30	12	with	with	ADP
dpc-5210	30	13	actively	actively	ADV
dpc-5210	30	14	progressive	progressive	ADJ
dpc-5210	30	15	vitiligo	vitiligo	NOUN
dpc-5210	30	16	patients	patient	NOUN
dpc-5210	30	17	whose	whose	DET
dpc-5210	30	18	condition	condition	NOUN
dpc-5210	30	19	is	be	AUX
dpc-5210	30	20	more	more	ADV
dpc-5210	30	21	difficult	difficult	ADJ
dpc-5210	30	22	to	to	PART
dpc-5210	30	23	control	control	VERB
dpc-5210	30	24	with	with	ADP
dpc-5210	30	25	systemic	systemic	ADJ
dpc-5210	30	26	treatments	treatment	NOUN
dpc-5210	30	27	.	.	PUNCT
dpc-5210	31	1	the	the	DET
dpc-5210	31	2	proportion	proportion	NOUN
dpc-5210	31	3	of	of	ADP
dpc-5210	31	4	patients	patient	NOUN
dpc-5210	31	5	experiencing	experience	VERB
dpc-5210	31	6	disease	disease	NOUN
dpc-5210	31	7	reactivation	reactivation	NOUN
dpc-5210	31	8	after	after	SCONJ
dpc-5210	31	9	systemic	systemic	ADJ
dpc-5210	31	10	immunosuppressants	immunosuppressant	NOUN
dpc-5210	31	11	is	be	AUX
dpc-5210	31	12	also	also	ADV
dpc-5210	31	13	seldom	seldom	ADV
dpc-5210	31	14	documented	document	VERB
dpc-5210	31	15	.	.	PUNCT
dpc-5210	32	1	objective	objective	NOUN
dpc-5210	32	2	in	in	ADP
dpc-5210	32	3	this	this	DET
dpc-5210	32	4	study	study	NOUN
dpc-5210	32	5	,	,	PUNCT
dpc-5210	32	6	we	we	PRON
dpc-5210	32	7	aimed	aim	VERB
dpc-5210	32	8	to	to	PART
dpc-5210	32	9	evaluate	evaluate	VERB
dpc-5210	32	10	the	the	DET
dpc-5210	32	11	clinical	clinical	ADJ
dpc-5210	32	12	features	feature	NOUN
dpc-5210	32	13	associated	associate	VERB
dpc-5210	32	14	with	with	ADP
dpc-5210	32	15	vitiligo	vitiligo	NOUN
dpc-5210	32	16	patients	patient	NOUN
dpc-5210	32	17	who	who	PRON
dpc-5210	32	18	require	require	VERB
dpc-5210	32	19	prolonged	prolonged	ADJ
dpc-5210	32	20	or	or	CCONJ
dpc-5210	32	21	multiple	multiple	ADJ
dpc-5210	32	22	courses	course	NOUN
dpc-5210	32	23	of	of	ADP
dpc-5210	32	24	systemic	systemic	ADJ
dpc-5210	32	25	immunosuppressants	immunosuppressant	NOUN
dpc-5210	32	26	to	to	PART
dpc-5210	32	27	control	control	VERB
dpc-5210	32	28	disease	disease	NOUN
dpc-5210	32	29	activity	activity	NOUN
dpc-5210	32	30	and	and	CCONJ
dpc-5210	32	31	to	to	PART
dpc-5210	32	32	report	report	VERB
dpc-5210	32	33	the	the	DET
dpc-5210	32	34	recurrence	recurrence	NOUN
dpc-5210	32	35	rate	rate	NOUN
dpc-5210	32	36	after	after	ADP
dpc-5210	32	37	systemic	systemic	ADJ
dpc-5210	32	38	treatment	treatment	NOUN
dpc-5210	32	39	.	.	PUNCT
dpc-5210	33	1	methods	method	NOUN
dpc-5210	33	2	this	this	PRON
dpc-5210	33	3	was	be	AUX
dpc-5210	33	4	a	a	DET
dpc-5210	33	5	single	single	ADJ
dpc-5210	33	6	-	-	PUNCT
dpc-5210	33	7	center	center	NOUN
dpc-5210	33	8	retrospective	retrospective	ADJ
dpc-5210	33	9	study	study	NOUN
dpc-5210	33	10	.	.	PUNCT
dpc-5210	34	1	patient	patient	ADJ
dpc-5210	34	2	records	record	NOUN
dpc-5210	34	3	from	from	ADP
dpc-5210	34	4	september	september	PROPN
dpc-5210	34	5	2017	2017	NUM
dpc-5210	34	6	to	to	ADP
dpc-5210	34	7	august	august	PROPN
dpc-5210	34	8	2023	2023	NUM
dpc-5210	34	9	at	at	ADP
dpc-5210	34	10	a	a	DET
dpc-5210	34	11	specialized	specialized	ADJ
dpc-5210	34	12	pigmentary	pigmentary	ADJ
dpc-5210	34	13	disease	disease	NOUN
dpc-5210	34	14	clinic	clinic	NOUN
dpc-5210	34	15	in	in	ADP
dpc-5210	34	16	a	a	DET
dpc-5210	34	17	tertiary	tertiary	ADJ
dpc-5210	34	18	teaching	teaching	NOUN
dpc-5210	34	19	hospital	hospital	NOUN
dpc-5210	34	20	were	be	AUX
dpc-5210	34	21	retrospectively	retrospectively	ADV
dpc-5210	34	22	reviewed	review	VERB
dpc-5210	34	23	.	.	PUNCT
dpc-5210	35	1	all	all	DET
dpc-5210	35	2	patients	patient	NOUN
dpc-5210	35	3	over	over	ADP
dpc-5210	35	4	age	age	NOUN
dpc-5210	35	5	18	18	NUM
dpc-5210	35	6	years	year	NOUN
dpc-5210	35	7	with	with	ADP
dpc-5210	35	8	non	non	ADJ
dpc-5210	35	9	-	-	ADJ
dpc-5210	35	10	segmental	segmental	ADJ
dpc-5210	35	11	active	active	ADJ
dpc-5210	35	12	vitiligo	vitiligo	NOUN
dpc-5210	35	13	and	and	CCONJ
dpc-5210	35	14	who	who	PRON
dpc-5210	35	15	had	have	AUX
dpc-5210	35	16	received	receive	VERB
dpc-5210	35	17	follow	follow	NOUN
dpc-5210	35	18	-	-	PUNCT
dpc-5210	35	19	up	up	NOUN
dpc-5210	35	20	for	for	ADP
dpc-5210	35	21	more	more	ADJ
dpc-5210	35	22	than	than	ADP
dpc-5210	35	23	six	six	NUM
dpc-5210	35	24	months	month	NOUN
dpc-5210	35	25	starting	start	VERB
dpc-5210	35	26	from	from	ADP
dpc-5210	35	27	the	the	DET
dpc-5210	35	28	day	day	NOUN
dpc-5210	35	29	of	of	ADP
dpc-5210	35	30	treatment	treatment	NOUN
dpc-5210	35	31	initiation	initiation	NOUN
dpc-5210	35	32	were	be	AUX
dpc-5210	35	33	included	include	VERB
dpc-5210	35	34	.	.	PUNCT
dpc-5210	36	1	our	our	PRON
dpc-5210	36	2	treatment	treatment	NOUN
dpc-5210	36	3	protocol	protocol	NOUN
dpc-5210	36	4	for	for	ADP
dpc-5210	36	5	active	active	ADJ
dpc-5210	36	6	vitiligo	vitiligo	NOUN
dpc-5210	36	7	is	be	AUX
dpc-5210	36	8	as	as	SCONJ
dpc-5210	36	9	follows	follow	VERB
dpc-5210	36	10	:	:	PUNCT
dpc-5210	36	11	oral	oral	ADJ
dpc-5210	36	12	dexamethasone	dexamethasone	NOUN
dpc-5210	36	13	2	2	NUM
dpc-5210	36	14	mg	mg	NOUN
dpc-5210	36	15	on	on	ADP
dpc-5210	36	16	two	two	NUM
dpc-5210	36	17	consecutive	consecutive	ADJ
dpc-5210	36	18	days	day	NOUN
dpc-5210	36	19	weekly	weekly	ADJ
dpc-5210	36	20	or	or	CCONJ
dpc-5210	36	21	oral	oral	ADJ
dpc-5210	36	22	methotrexate	methotrexate	NOUN
dpc-5210	36	23	7.5	7.5	NUM
dpc-5210	36	24	mg	mg	NOUN
dpc-5210	36	25	weekly	weekly	NOUN
dpc-5210	36	26	for	for	ADP
dpc-5210	36	27	12	12	NUM
dpc-5210	36	28	to	to	PART
dpc-5210	36	29	16	16	NUM
dpc-5210	36	30	weeks	week	NOUN
dpc-5210	36	31	.	.	PUNCT
dpc-5210	37	1	if	if	SCONJ
dpc-5210	37	2	continuous	continuous	ADJ
dpc-5210	37	3	disease	disease	NOUN
dpc-5210	37	4	progression	progression	NOUN
dpc-5210	37	5	is	be	AUX
dpc-5210	37	6	observed	observe	VERB
dpc-5210	37	7	,	,	PUNCT
dpc-5210	37	8	oral	oral	ADJ
dpc-5210	37	9	immunosuppressants	immunosuppressant	NOUN
dpc-5210	37	10	are	be	AUX
dpc-5210	37	11	prolonged	prolong	VERB
dpc-5210	37	12	until	until	ADP
dpc-5210	37	13	stabilization	stabilization	NOUN
dpc-5210	37	14	.	.	PUNCT
dpc-5210	38	1	active	active	ADJ
dpc-5210	38	2	vitiligo	vitiligo	NOUN
dpc-5210	38	3	is	be	AUX
dpc-5210	38	4	defined	define	VERB
dpc-5210	38	5	as	as	ADP
dpc-5210	38	6	having	have	VERB
dpc-5210	38	7	any	any	DET
dpc-5210	38	8	newly	newly	ADV
dpc-5210	38	9	developed	develop	VERB
dpc-5210	38	10	depigmented	depigmented	ADJ
dpc-5210	38	11	lesions	lesion	NOUN
dpc-5210	38	12	or	or	CCONJ
dpc-5210	38	13	nontreated	nontreate	VERB
dpc-5210	38	14	vitiligo	vitiligo	NOUN
dpc-5210	38	15	lesions	lesion	NOUN
dpc-5210	38	16	within	within	ADP
dpc-5210	38	17	the	the	DET
dpc-5210	38	18	preceding	precede	VERB
dpc-5210	38	19	three	three	NUM
dpc-5210	38	20	months	month	NOUN
dpc-5210	38	21	.	.	PUNCT
dpc-5210	39	1	disease	disease	NOUN
dpc-5210	39	2	stabilization	stabilization	NOUN
dpc-5210	39	3	is	be	AUX
dpc-5210	39	4	defined	define	VERB
dpc-5210	39	5	as	as	ADP
dpc-5210	39	6	no	no	DET
dpc-5210	39	7	new	new	ADJ
dpc-5210	39	8	depigmented	depigmented	ADJ
dpc-5210	39	9	lesion	lesion	NOUN
dpc-5210	39	10	observed	observe	VERB
dpc-5210	39	11	for	for	ADP
dpc-5210	39	12	three	three	NUM
dpc-5210	39	13	months	month	NOUN
dpc-5210	39	14	.	.	PUNCT
dpc-5210	40	1	systemic	systemic	ADJ
dpc-5210	40	2	therapy	therapy	NOUN
dpc-5210	40	3	was	be	AUX
dpc-5210	40	4	resumed	resume	VERB
dpc-5210	40	5	if	if	SCONJ
dpc-5210	40	6	a	a	DET
dpc-5210	40	7	recurrence	recurrence	NOUN
dpc-5210	40	8	of	of	ADP
dpc-5210	40	9	disease	disease	NOUN
dpc-5210	40	10	activity	activity	NOUN
dpc-5210	40	11	was	be	AUX
dpc-5210	40	12	observed	observe	VERB
dpc-5210	40	13	.	.	PUNCT
dpc-5210	41	1	all	all	DET
dpc-5210	41	2	patients	patient	NOUN
dpc-5210	41	3	received	receive	VERB
dpc-5210	41	4	low	low	ADJ
dpc-5210	41	5	-	-	PUNCT
dpc-5210	41	6	dose	dose	NOUN
dpc-5210	41	7	maintenance	maintenance	NOUN
dpc-5210	41	8	phototherapy	phototherapy	NOUN
dpc-5210	41	9	for	for	ADP
dpc-5210	41	10	repigmentation	repigmentation	NOUN
dpc-5210	41	11	[	[	X
dpc-5210	41	12	11	11	NUM
dpc-5210	41	13	]	]	PUNCT
dpc-5210	41	14	.	.	PUNCT
dpc-5210	42	1	patients	patient	NOUN
dpc-5210	42	2	who	who	PRON
dpc-5210	42	3	refused	refuse	VERB
dpc-5210	42	4	systemic	systemic	ADJ
dpc-5210	42	5	therapy	therapy	NOUN
dpc-5210	42	6	,	,	PUNCT
dpc-5210	42	7	were	be	AUX
dpc-5210	42	8	under	under	ADP
dpc-5210	42	9	immunosuppressants	immunosuppressant	NOUN
dpc-5210	42	10	for	for	ADP
dpc-5210	42	11	other	other	ADJ
dpc-5210	42	12	diseases	disease	NOUN
dpc-5210	42	13	,	,	PUNCT
dpc-5210	42	14	or	or	CCONJ
dpc-5210	42	15	were	be	AUX
dpc-5210	42	16	receiving	receive	VERB
dpc-5210	42	17	treatment	treatment	NOUN
dpc-5210	42	18	for	for	ADP
dpc-5210	42	19	active	active	ADJ
dpc-5210	42	20	cancer	cancer	NOUN
dpc-5210	42	21	were	be	AUX
dpc-5210	42	22	excluded	exclude	VERB
dpc-5210	42	23	.	.	PUNCT
dpc-5210	43	1	this	this	DET
dpc-5210	43	2	study	study	NOUN
dpc-5210	43	3	was	be	AUX
dpc-5210	43	4	approved	approve	VERB
dpc-5210	43	5	by	by	ADP
dpc-5210	43	6	the	the	DET
dpc-5210	43	7	hospital	hospital	NOUN
dpc-5210	43	8	institutional	institutional	PROPN
dpc-5210	43	9	review	review	PROPN
dpc-5210	43	10	board	board	NOUN
dpc-5210	43	11	(	(	PUNCT
dpc-5210	43	12	kmuhirb	kmuhirb	PROPN
dpc-5210	43	13	-	-	PUNCT
dpc-5210	43	14	e(i)-20240106	e(i)-20240106	NOUN
dpc-5210	43	15	)	)	PUNCT
dpc-5210	43	16	.	.	PUNCT
dpc-5210	44	1	to	to	PART
dpc-5210	44	2	identify	identify	VERB
dpc-5210	44	3	patients	patient	NOUN
dpc-5210	44	4	whose	whose	DET
dpc-5210	44	5	condition	condition	NOUN
dpc-5210	44	6	was	be	AUX
dpc-5210	44	7	more	more	ADV
dpc-5210	44	8	difficult	difficult	ADJ
dpc-5210	44	9	to	to	PART
dpc-5210	44	10	stabilize	stabilize	VERB
dpc-5210	44	11	under	under	ADP
dpc-5210	44	12	the	the	DET
dpc-5210	44	13	above	above	ADJ
dpc-5210	44	14	treatment	treatment	NOUN
dpc-5210	44	15	protocol	protocol	NOUN
dpc-5210	44	16	,	,	PUNCT
dpc-5210	44	17	the	the	DET
dpc-5210	44	18	enrolled	enrol	VERB
dpc-5210	44	19	patients	patient	NOUN
dpc-5210	44	20	were	be	AUX
dpc-5210	44	21	grouped	group	VERB
dpc-5210	44	22	into	into	ADP
dpc-5210	44	23	three	three	NUM
dpc-5210	44	24	groups	group	NOUN
dpc-5210	44	25	.	.	PUNCT
dpc-5210	45	1	the	the	DET
dpc-5210	45	2	first	first	ADJ
dpc-5210	45	3	group	group	NOUN
dpc-5210	45	4	included	include	VERB
dpc-5210	45	5	patients	patient	NOUN
dpc-5210	45	6	who	who	PRON
dpc-5210	45	7	only	only	ADV
dpc-5210	45	8	required	require	VERB
dpc-5210	45	9	oral	oral	ADJ
dpc-5210	45	10	systemic	systemic	ADJ
dpc-5210	45	11	immunosuppressants	immunosuppressant	NOUN
dpc-5210	45	12	for	for	ADP
dpc-5210	45	13	≤16	≤16	NOUN
dpc-5210	45	14	weeks	week	NOUN
dpc-5210	45	15	,	,	PUNCT
dpc-5210	45	16	without	without	ADP
dpc-5210	45	17	reactivation	reactivation	NOUN
dpc-5210	45	18	within	within	ADP
dpc-5210	45	19	six	six	NUM
dpc-5210	45	20	months	month	NOUN
dpc-5210	45	21	from	from	ADP
dpc-5210	45	22	treatment	treatment	NOUN
dpc-5210	45	23	initiation	initiation	NOUN
dpc-5210	45	24	.	.	PUNCT
dpc-5210	46	1	the	the	DET
dpc-5210	46	2	second	second	ADJ
dpc-5210	46	3	group	group	NOUN
dpc-5210	46	4	included	include	VERB
dpc-5210	46	5	patients	patient	NOUN
dpc-5210	46	6	who	who	PRON
dpc-5210	46	7	required	require	VERB
dpc-5210	46	8	continuous	continuous	ADJ
dpc-5210	46	9	systemic	systemic	ADJ
dpc-5210	46	10	immunosuppressants	immunosuppressant	NOUN
dpc-5210	46	11	for	for	ADP
dpc-5210	46	12	more	more	ADJ
dpc-5210	46	13	than	than	ADP
dpc-5210	46	14	16	16	NUM
dpc-5210	46	15	weeks	week	NOUN
dpc-5210	46	16	.	.	PUNCT
dpc-5210	47	1	patients	patient	NOUN
dpc-5210	47	2	whose	whose	DET
dpc-5210	47	3	disease	disease	NOUN
dpc-5210	47	4	activity	activity	NOUN
dpc-5210	47	5	could	could	AUX
dpc-5210	47	6	be	be	AUX
dpc-5210	47	7	controlled	control	VERB
dpc-5210	47	8	with	with	ADP
dpc-5210	47	9	±16	±16	PROPN
dpc-5210	47	10	weeks	week	NOUN
dpc-5210	47	11	of	of	ADP
dpc-5210	47	12	oral	oral	ADJ
dpc-5210	47	13	immunosuppressants	immunosuppressant	NOUN
dpc-5210	47	14	but	but	CCONJ
dpc-5210	47	15	which	which	PRON
dpc-5210	47	16	recurred	recur	VERB
dpc-5210	47	17	within	within	ADP
dpc-5210	47	18	six	six	NUM
dpc-5210	47	19	months	month	NOUN
dpc-5210	47	20	from	from	ADP
dpc-5210	47	21	treatment	treatment	NOUN
dpc-5210	47	22	initiation	initiation	NOUN
dpc-5210	47	23	were	be	AUX
dpc-5210	47	24	included	include	VERB
dpc-5210	47	25	in	in	ADP
dpc-5210	47	26	the	the	DET
dpc-5210	47	27	third	third	ADJ
dpc-5210	47	28	group	group	NOUN
dpc-5210	47	29	.	.	PUNCT
dpc-5210	48	1	statistical	statistical	ADJ
dpc-5210	48	2	analyses	analysis	NOUN
dpc-5210	48	3	were	be	AUX
dpc-5210	48	4	performed	perform	VERB
dpc-5210	48	5	by	by	ADP
dpc-5210	48	6	r	r	NOUN
dpc-5210	48	7	software	software	NOUN
dpc-5210	48	8	version	version	NOUN
dpc-5210	48	9	3.6.3	3.6.3	PROPN
dpc-5210	48	10	.	.	PUNCT
dpc-5210	49	1	one	one	NUM
dpc-5210	49	2	-	-	PUNCT
dpc-5210	49	3	way	way	NOUN
dpc-5210	49	4	anova	anova	PROPN
dpc-5210	49	5	was	be	AUX
dpc-5210	49	6	used	use	VERB
dpc-5210	49	7	to	to	PART
dpc-5210	49	8	compare	compare	VERB
dpc-5210	49	9	the	the	DET
dpc-5210	49	10	mean	mean	ADJ
dpc-5210	49	11	ages	age	NOUN
dpc-5210	49	12	,	,	PUNCT
dpc-5210	49	13	and	and	CCONJ
dpc-5210	49	14	fisher	fisher	PROPN
dpc-5210	49	15	’s	’s	PART
dpc-5210	49	16	exact	exact	ADJ
dpc-5210	49	17	test	test	NOUN
dpc-5210	49	18	was	be	AUX
dpc-5210	49	19	used	use	VERB
dpc-5210	49	20	to	to	PART
dpc-5210	49	21	compare	compare	VERB
dpc-5210	49	22	the	the	DET
dpc-5210	49	23	percentage	percentage	NOUN
dpc-5210	49	24	frequencies	frequency	NOUN
dpc-5210	49	25	among	among	ADP
dpc-5210	49	26	categorical	categorical	ADJ
dpc-5210	49	27	variables	variable	NOUN
dpc-5210	49	28	.	.	PUNCT
dpc-5210	50	1	a	a	DET
dpc-5210	50	2	p	p	ADJ
dpc-5210	50	3	-	-	PUNCT
dpc-5210	50	4	value	value	NOUN
dpc-5210	50	5	equal	equal	ADJ
dpc-5210	50	6	to	to	ADP
dpc-5210	50	7	or	or	CCONJ
dpc-5210	50	8	less	less	ADJ
dpc-5210	50	9	than	than	ADP
dpc-5210	50	10	0.05	0.05	NUM
dpc-5210	50	11	was	be	AUX
dpc-5210	50	12	considered	consider	VERB
dpc-5210	50	13	significant	significant	ADJ
dpc-5210	50	14	.	.	PUNCT
dpc-5210	51	1	post	post	VERB
dpc-5210	51	2	hoc	hoc	X
dpc-5210	51	3	analyses	analysis	NOUN
dpc-5210	51	4	were	be	AUX
dpc-5210	51	5	adjusted	adjust	VERB
dpc-5210	51	6	using	use	VERB
dpc-5210	51	7	tukey	tukey	NOUN
dpc-5210	51	8	’s	’s	PART
dpc-5210	51	9	 	 	SPACE
dpc-5210	51	10	post	post	X
dpc-5210	51	11	hoc	hoc	X
dpc-5210	51	12	 	 	SPACE
dpc-5210	51	13	test	test	NOUN
dpc-5210	51	14	or	or	CCONJ
dpc-5210	51	15	bonferroni	bonferroni	NOUN
dpc-5210	51	16	correction	correction	NOUN
dpc-5210	51	17	.	.	PUNCT
dpc-5210	52	1	in	in	ADP
dpc-5210	52	2	order	order	NOUN
dpc-5210	52	3	to	to	PART
dpc-5210	52	4	control	control	VERB
dpc-5210	52	5	for	for	ADP
dpc-5210	52	6	confounding	confound	VERB
dpc-5210	52	7	factors	factor	NOUN
dpc-5210	52	8	,	,	PUNCT
dpc-5210	52	9	multivariate	multivariate	NOUN
dpc-5210	52	10	logistic	logistic	ADJ
dpc-5210	52	11	regression	regression	NOUN
dpc-5210	52	12	was	be	AUX
dpc-5210	52	13	implemented	implement	VERB
dpc-5210	52	14	to	to	PART
dpc-5210	52	15	identify	identify	VERB
dpc-5210	52	16	factors	factor	NOUN
dpc-5210	52	17	associated	associate	VERB
dpc-5210	52	18	with	with	ADP
dpc-5210	52	19	active	active	ADJ
dpc-5210	52	20	vitiligo	vitiligo	NOUN
dpc-5210	52	21	more	more	ADV
dpc-5210	52	22	difficult	difficult	ADJ
dpc-5210	52	23	to	to	PART
dpc-5210	52	24	stabilize	stabilize	VERB
dpc-5210	52	25	(	(	PUNCT
dpc-5210	52	26	group	group	NOUN
dpc-5210	52	27	2	2	NUM
dpc-5210	52	28	)	)	PUNCT
dpc-5210	52	29	.	.	PUNCT
dpc-5210	53	1	bidirectional	bidirectional	ADJ
dpc-5210	53	2	stepwise	stepwise	PROPN
dpc-5210	53	3	selection	selection	NOUN
dpc-5210	53	4	was	be	AUX
dpc-5210	53	5	used	use	VERB
dpc-5210	53	6	to	to	PART
dpc-5210	53	7	select	select	VERB
dpc-5210	53	8	relevant	relevant	ADJ
dpc-5210	53	9	variables	variable	NOUN
dpc-5210	53	10	for	for	ADP
dpc-5210	53	11	the	the	DET
dpc-5210	53	12	logistic	logistic	ADJ
dpc-5210	53	13	regression	regression	NOUN
dpc-5210	53	14	model	model	NOUN
dpc-5210	53	15	.	.	PUNCT
dpc-5210	54	1	(	(	PUNCT
dpc-5210	54	2	or	or	CCONJ
dpc-5210	54	3	):	):	PUNCT
dpc-5210	54	4	0.968	0.968	NUM
dpc-5210	54	5	;	;	PUNCT
dpc-5210	54	6	p=0.016	p=0.016	NUM
dpc-5210	54	7	)	)	PUNCT
dpc-5210	54	8	and	and	CCONJ
dpc-5210	54	9	facial	facial	ADJ
dpc-5210	54	10	involvement	involvement	NOUN
dpc-5210	54	11	(	(	PUNCT
dpc-5210	54	12	or	or	CCONJ
dpc-5210	54	13	:	:	PUNCT
dpc-5210	54	14	0.432	0.432	NUM
dpc-5210	54	15	;	;	PUNCT
dpc-5210	54	16	p=0.023	p=0.023	NUM
dpc-5210	54	17	)	)	PUNCT
dpc-5210	54	18	were	be	AUX
dpc-5210	54	19	identified	identify	VERB
dpc-5210	54	20	as	as	ADP
dpc-5210	54	21	significant	significant	ADJ
dpc-5210	54	22	factors	factor	NOUN
dpc-5210	54	23	associated	associate	VERB
dpc-5210	54	24	with	with	ADP
dpc-5210	54	25	decreased	decrease	VERB
dpc-5210	54	26	risk	risk	NOUN
dpc-5210	54	27	for	for	ADP
dpc-5210	54	28	group	group	NOUN
dpc-5210	54	29	2	2	NUM
dpc-5210	54	30	.	.	PUNCT
dpc-5210	55	1	at	at	ADP
dpc-5210	55	2	one	one	NUM
dpc-5210	55	3	-	-	PUNCT
dpc-5210	55	4	year	year	NOUN
dpc-5210	55	5	follow	follow	NOUN
dpc-5210	55	6	-	-	PUNCT
dpc-5210	55	7	up	up	NOUN
dpc-5210	55	8	,	,	PUNCT
dpc-5210	55	9	10.89	10.89	NUM
dpc-5210	55	10	%	%	NOUN
dpc-5210	55	11	of	of	ADP
dpc-5210	55	12	group	group	NOUN
dpc-5210	55	13	1	1	NUM
dpc-5210	55	14	patients	patient	NOUN
dpc-5210	55	15	experienced	experience	VERB
dpc-5210	55	16	disease	disease	NOUN
dpc-5210	55	17	reactivation	reactivation	NOUN
dpc-5210	55	18	.	.	PUNCT
dpc-5210	56	1	conclusions	conclusion	NOUN
dpc-5210	56	2	:	:	PUNCT
dpc-5210	56	3	older	old	ADJ
dpc-5210	56	4	patients	patient	NOUN
dpc-5210	56	5	and	and	CCONJ
dpc-5210	56	6	patients	patient	NOUN
dpc-5210	56	7	with	with	ADP
dpc-5210	56	8	facial	facial	ADJ
dpc-5210	56	9	involvement	involvement	NOUN
dpc-5210	56	10	were	be	AUX
dpc-5210	56	11	more	more	ADV
dpc-5210	56	12	likely	likely	ADJ
dpc-5210	56	13	to	to	PART
dpc-5210	56	14	achieve	achieve	VERB
dpc-5210	56	15	disease	disease	NOUN
dpc-5210	56	16	stabilization	stabilization	NOUN
dpc-5210	56	17	.	.	PUNCT
dpc-5210	57	1	careful	careful	ADJ
dpc-5210	57	2	photo	photo	NOUN
dpc-5210	57	3	documentation	documentation	NOUN
dpc-5210	57	4	is	be	AUX
dpc-5210	57	5	essential	essential	ADJ
dpc-5210	57	6	to	to	ADP
dpc-5210	57	7	optimal	optimal	ADJ
dpc-5210	57	8	vitiligo	vitiligo	NOUN
dpc-5210	57	9	management	management	NOUN
dpc-5210	57	10	as	as	SCONJ
dpc-5210	57	11	disease	disease	NOUN
dpc-5210	57	12	reactivation	reactivation	NOUN
dpc-5210	57	13	is	be	AUX
dpc-5210	57	14	common	common	ADJ
dpc-5210	57	15	after	after	ADP
dpc-5210	57	16	systemic	systemic	ADJ
dpc-5210	57	17	treatment	treatment	NOUN
dpc-5210	57	18	,	,	PUNCT
dpc-5210	57	19	even	even	ADV
dpc-5210	57	20	if	if	SCONJ
dpc-5210	57	21	initial	initial	ADJ
dpc-5210	57	22	disease	disease	NOUN
dpc-5210	57	23	stabilization	stabilization	NOUN
dpc-5210	57	24	is	be	AUX
dpc-5210	57	25	achieved	achieve	VERB
dpc-5210	57	26	.	.	PUNCT
dpc-5210	58	1	original	original	ADJ
dpc-5210	58	2	article	article	NOUN
dpc-5210	58	3	|	|	ADV
dpc-5210	58	4	dermatol	dermatol	ADJ
dpc-5210	58	5	pract	pract	NOUN
dpc-5210	58	6	concept	concept	NOUN
dpc-5210	58	7	.	.	PUNCT
dpc-5210	59	1	2025;15(4):5210	2025;15(4):5210	PROPN
dpc-5210	59	2	3	3	NUM
dpc-5210	59	3	results	result	VERB
dpc-5210	59	4	a	a	DET
dpc-5210	59	5	total	total	NOUN
dpc-5210	59	6	of	of	ADP
dpc-5210	59	7	166	166	NUM
dpc-5210	59	8	patients	patient	NOUN
dpc-5210	59	9	with	with	ADP
dpc-5210	59	10	active	active	ADJ
dpc-5210	59	11	vitiligo	vitiligo	NOUN
dpc-5210	59	12	received	receive	VERB
dpc-5210	59	13	follow	follow	NOUN
dpc-5210	59	14	-	-	PUNCT
dpc-5210	59	15	up	up	NOUN
dpc-5210	59	16	for	for	ADP
dpc-5210	59	17	more	more	ADJ
dpc-5210	59	18	than	than	ADP
dpc-5210	59	19	six	six	NUM
dpc-5210	59	20	months	month	NOUN
dpc-5210	59	21	in	in	ADP
dpc-5210	59	22	the	the	DET
dpc-5210	59	23	study	study	NOUN
dpc-5210	59	24	period	period	NOUN
dpc-5210	59	25	.	.	PUNCT
dpc-5210	60	1	after	after	ADP
dpc-5210	60	2	excluding	exclude	VERB
dpc-5210	60	3	two	two	NUM
dpc-5210	60	4	patients	patient	NOUN
dpc-5210	60	5	under	under	ADP
dpc-5210	60	6	concomitant	concomitant	ADJ
dpc-5210	60	7	cancer	cancer	NOUN
dpc-5210	60	8	treatment	treatment	NOUN
dpc-5210	60	9	,	,	PUNCT
dpc-5210	60	10	two	two	NUM
dpc-5210	60	11	patients	patient	NOUN
dpc-5210	60	12	who	who	PRON
dpc-5210	60	13	refused	refuse	VERB
dpc-5210	60	14	systemic	systemic	ADJ
dpc-5210	60	15	treatment	treatment	NOUN
dpc-5210	60	16	,	,	PUNCT
dpc-5210	60	17	two	two	NUM
dpc-5210	60	18	patients	patient	NOUN
dpc-5210	60	19	under	under	ADP
dpc-5210	60	20	immunosuppressants	immunosuppressant	NOUN
dpc-5210	60	21	for	for	ADP
dpc-5210	60	22	other	other	ADJ
dpc-5210	60	23	diseases	disease	NOUN
dpc-5210	60	24	(	(	PUNCT
dpc-5210	60	25	sjögren	sjögren	PROPN
dpc-5210	60	26	’s	’s	PART
dpc-5210	60	27	syndrome	syndrome	NOUN
dpc-5210	60	28	and	and	CCONJ
dpc-5210	60	29	psoriasis	psoriasis	NOUN
dpc-5210	60	30	)	)	PUNCT
dpc-5210	60	31	,	,	PUNCT
dpc-5210	60	32	and	and	CCONJ
dpc-5210	60	33	one	one	NUM
dpc-5210	60	34	pregnant	pregnant	ADJ
dpc-5210	60	35	patient	patient	NOUN
dpc-5210	60	36	,	,	PUNCT
dpc-5210	60	37	a	a	DET
dpc-5210	60	38	total	total	NOUN
dpc-5210	60	39	of	of	ADP
dpc-5210	60	40	159	159	NUM
dpc-5210	60	41	patients	patient	NOUN
dpc-5210	60	42	were	be	AUX
dpc-5210	60	43	enrolled	enrol	VERB
dpc-5210	60	44	.	.	PUNCT
dpc-5210	61	1	the	the	DET
dpc-5210	61	2	first	first	ADJ
dpc-5210	61	3	group	group	NOUN
dpc-5210	61	4	consisted	consist	VERB
dpc-5210	61	5	of	of	ADP
dpc-5210	61	6	101	101	NUM
dpc-5210	61	7	(	(	PUNCT
dpc-5210	61	8	63.52	63.52	NUM
dpc-5210	61	9	%	%	NOUN
dpc-5210	61	10	)	)	PUNCT
dpc-5210	61	11	patients	patient	NOUN
dpc-5210	61	12	,	,	PUNCT
dpc-5210	61	13	the	the	DET
dpc-5210	61	14	second	second	ADJ
dpc-5210	61	15	group	group	NOUN
dpc-5210	61	16	included	include	VERB
dpc-5210	61	17	51	51	NUM
dpc-5210	61	18	(	(	PUNCT
dpc-5210	61	19	32.08	32.08	NUM
dpc-5210	61	20	%	%	NOUN
dpc-5210	61	21	)	)	PUNCT
dpc-5210	61	22	patients	patient	NOUN
dpc-5210	61	23	,	,	PUNCT
dpc-5210	61	24	and	and	CCONJ
dpc-5210	61	25	the	the	DET
dpc-5210	61	26	third	third	ADJ
dpc-5210	61	27	group	group	NOUN
dpc-5210	61	28	consisted	consist	VERB
dpc-5210	61	29	of	of	ADP
dpc-5210	61	30	seven	seven	NUM
dpc-5210	61	31	(	(	PUNCT
dpc-5210	61	32	4.4	4.4	NUM
dpc-5210	61	33	%	%	NOUN
dpc-5210	61	34	)	)	PUNCT
dpc-5210	61	35	patients	patient	NOUN
dpc-5210	61	36	.	.	PUNCT
dpc-5210	62	1	the	the	DET
dpc-5210	62	2	characteristics	characteristic	NOUN
dpc-5210	62	3	of	of	ADP
dpc-5210	62	4	patients	patient	NOUN
dpc-5210	62	5	are	be	AUX
dpc-5210	62	6	summarized	summarize	VERB
dpc-5210	62	7	in	in	ADP
dpc-5210	62	8	table	table	NOUN
dpc-5210	62	9	1	1	NUM
dpc-5210	62	10	.	.	PUNCT
dpc-5210	63	1	patients	patient	NOUN
dpc-5210	63	2	in	in	ADP
dpc-5210	63	3	group	group	NOUN
dpc-5210	63	4	2	2	NUM
dpc-5210	63	5	were	be	AUX
dpc-5210	63	6	significantly	significantly	ADV
dpc-5210	63	7	younger	young	ADJ
dpc-5210	63	8	than	than	ADP
dpc-5210	63	9	patients	patient	NOUN
dpc-5210	63	10	in	in	ADP
dpc-5210	63	11	group	group	NOUN
dpc-5210	63	12	1	1	NUM
dpc-5210	63	13	(	(	PUNCT
dpc-5210	63	14	39.69±11.51	39.69±11.51	PROPN
dpc-5210	63	15	vs.	vs.	ADP
dpc-5210	63	16	46.47±14.91	46.47±14.91	NOUN
dpc-5210	63	17	years	year	NOUN
dpc-5210	63	18	;	;	PUNCT
dpc-5210	63	19	tukey	tukey	PROPN
dpc-5210	63	20	’s	’s	NOUN
dpc-5210	63	21	  	  	SPACE
dpc-5210	63	22	post	post	X
dpc-5210	63	23	hoc	hoc	X
dpc-5210	63	24	  	  	SPACE
dpc-5210	63	25	test	test	NOUN
dpc-5210	63	26	p=0.013	p=0.013	NOUN
dpc-5210	63	27	)	)	PUNCT
dpc-5210	63	28	.	.	PUNCT
dpc-5210	64	1	after	after	ADP
dpc-5210	64	2	post	post	ADJ
dpc-5210	64	3	-	-	ADJ
dpc-5210	64	4	hoc	hoc	ADJ
dpc-5210	64	5	analysis	analysis	NOUN
dpc-5210	64	6	with	with	ADP
dpc-5210	64	7	the	the	DET
dpc-5210	64	8	bonferroni	bonferroni	NOUN
dpc-5210	64	9	correction	correction	NOUN
dpc-5210	64	10	(	(	PUNCT
dpc-5210	64	11	p	p	X
dpc-5210	64	12	<	<	X
dpc-5210	64	13	0.05/3	0.05/3	ADJ
dpc-5210	64	14	=	=	SYM
dpc-5210	64	15	0.017	0.017	NUM
dpc-5210	64	16	was	be	AUX
dpc-5210	64	17	considered	consider	VERB
dpc-5210	64	18	significant	significant	ADJ
dpc-5210	64	19	)	)	PUNCT
dpc-5210	64	20	,	,	PUNCT
dpc-5210	64	21	the	the	DET
dpc-5210	64	22	proportion	proportion	NOUN
dpc-5210	64	23	of	of	ADP
dpc-5210	64	24	patients	patient	NOUN
dpc-5210	64	25	with	with	ADP
dpc-5210	64	26	facial	facial	ADJ
dpc-5210	64	27	involvement	involvement	NOUN
dpc-5210	64	28	was	be	AUX
dpc-5210	64	29	significantly	significantly	ADV
dpc-5210	64	30	lower	low	ADJ
dpc-5210	64	31	in	in	ADP
dpc-5210	64	32	group	group	NOUN
dpc-5210	64	33	2	2	NUM
dpc-5210	64	34	compared	compare	VERB
dpc-5210	64	35	to	to	ADP
dpc-5210	64	36	group	group	NOUN
dpc-5210	64	37	1	1	NUM
dpc-5210	64	38	(	(	PUNCT
dpc-5210	64	39	56.86	56.86	NUM
dpc-5210	64	40	%	%	NOUN
dpc-5210	64	41	vs.	vs.	ADP
dpc-5210	64	42	76.24	76.24	NUM
dpc-5210	64	43	%	%	NOUN
dpc-5210	64	44	vs.	vs.	NOUN
dpc-5210	64	45	;	;	PUNCT
dpc-5210	64	46	p=0.016	p=0.016	NUM
dpc-5210	64	47	)	)	PUNCT
dpc-5210	64	48	.	.	PUNCT
dpc-5210	65	1	age	age	NOUN
dpc-5210	65	2	and	and	CCONJ
dpc-5210	65	3	facial	facial	ADJ
dpc-5210	65	4	involvement	involvement	NOUN
dpc-5210	65	5	were	be	AUX
dpc-5210	65	6	independent	independent	ADJ
dpc-5210	65	7	variables	variable	NOUN
dpc-5210	65	8	selected	select	VERB
dpc-5210	65	9	in	in	ADP
dpc-5210	65	10	the	the	DET
dpc-5210	65	11	multivariate	multivariate	NOUN
dpc-5210	65	12	logistic	logistic	ADJ
dpc-5210	65	13	regression	regression	NOUN
dpc-5210	65	14	model	model	NOUN
dpc-5210	65	15	to	to	PART
dpc-5210	65	16	predict	predict	VERB
dpc-5210	65	17	patients	patient	NOUN
dpc-5210	65	18	in	in	ADP
dpc-5210	65	19	group	group	NOUN
dpc-5210	65	20	2	2	NUM
dpc-5210	65	21	using	use	VERB
dpc-5210	65	22	bidirectional	bidirectional	ADJ
dpc-5210	65	23	stepwise	stepwise	PROPN
dpc-5210	65	24	selection	selection	NOUN
dpc-5210	65	25	.	.	PUNCT
dpc-5210	66	1	both	both	DET
dpc-5210	66	2	age	age	NOUN
dpc-5210	66	3	(	(	PUNCT
dpc-5210	66	4	β=	β=	NOUN
dpc-5210	66	5	-0.033	-0.033	ADJ
dpc-5210	66	6	;	;	PUNCT
dpc-5210	66	7	odds	odd	NOUN
dpc-5210	66	8	ratio	ratio	NOUN
dpc-5210	66	9	(	(	PUNCT
dpc-5210	66	10	or	or	CCONJ
dpc-5210	66	11	):	):	PUNCT
dpc-5210	66	12	0.968	0.968	NUM
dpc-5210	66	13	;	;	PUNCT
dpc-5210	66	14	95	95	NUM
dpc-5210	66	15	%	%	NOUN
dpc-5210	66	16	confidence	confidence	NOUN
dpc-5210	66	17	interval	interval	NOUN
dpc-5210	66	18	(	(	PUNCT
dpc-5210	66	19	ci	ci	NOUN
dpc-5210	66	20	):	):	PUNCT
dpc-5210	66	21	-0.059	-0.059	PROPN
dpc-5210	66	22	–	–	PUNCT
dpc-5210	66	23	-0.006	-0.006	PROPN
dpc-5210	66	24	;	;	PUNCT
dpc-5210	66	25	p=0.016	p=0.016	NUM
dpc-5210	66	26	)	)	PUNCT
dpc-5210	66	27	and	and	CCONJ
dpc-5210	66	28	facial	facial	ADJ
dpc-5210	66	29	involvement	involvement	NOUN
dpc-5210	66	30	(	(	PUNCT
dpc-5210	66	31	β=	β=	NOUN
dpc-5210	66	32	0.84	0.84	NUM
dpc-5210	66	33	;	;	PUNCT
dpc-5210	66	34	or	or	CCONJ
dpc-5210	66	35	:	:	PUNCT
dpc-5210	66	36	0.432	0.432	NUM
dpc-5210	66	37	;	;	PUNCT
dpc-5210	66	38	95	95	NUM
dpc-5210	66	39	%	%	NOUN
dpc-5210	66	40	ci	ci	NOUN
dpc-5210	66	41	:	:	PUNCT
dpc-5210	66	42	-1.568	-1.568	NUM
dpc-5210	66	43	–	–	PUNCT
dpc-5210	66	44	-0.115	-0.115	NOUN
dpc-5210	66	45	;	;	PUNCT
dpc-5210	66	46	p=0.023	p=0.023	X
dpc-5210	66	47	)	)	PUNCT
dpc-5210	66	48	were	be	AUX
dpc-5210	66	49	identified	identify	VERB
dpc-5210	66	50	as	as	ADP
dpc-5210	66	51	significant	significant	ADJ
dpc-5210	66	52	factors	factor	NOUN
dpc-5210	66	53	associated	associate	VERB
dpc-5210	66	54	with	with	ADP
dpc-5210	66	55	decreased	decrease	VERB
dpc-5210	66	56	risk	risk	NOUN
dpc-5210	66	57	for	for	ADP
dpc-5210	66	58	group	group	NOUN
dpc-5210	66	59	2	2	NUM
dpc-5210	66	60	.	.	PUNCT
dpc-5210	67	1	we	we	PRON
dpc-5210	67	2	further	far	ADV
dpc-5210	67	3	examined	examine	VERB
dpc-5210	67	4	the	the	DET
dpc-5210	67	5	number	number	NOUN
dpc-5210	67	6	of	of	ADP
dpc-5210	67	7	patients	patient	NOUN
dpc-5210	67	8	requiring	require	VERB
dpc-5210	67	9	subsequent	subsequent	ADJ
dpc-5210	67	10	systemic	systemic	ADJ
dpc-5210	67	11	treatment	treatment	NOUN
dpc-5210	67	12	due	due	ADP
dpc-5210	67	13	to	to	ADP
dpc-5210	67	14	disease	disease	NOUN
dpc-5210	67	15	reactivation	reactivation	NOUN
dpc-5210	67	16	at	at	ADP
dpc-5210	67	17	1	1	NUM
dpc-5210	67	18	-	-	PUNCT
dpc-5210	67	19	year	year	NOUN
dpc-5210	67	20	follow	follow	NOUN
dpc-5210	67	21	-	-	PUNCT
dpc-5210	67	22	up	up	NOUN
dpc-5210	67	23	despite	despite	SCONJ
dpc-5210	67	24	initial	initial	ADJ
dpc-5210	67	25	disease	disease	NOUN
dpc-5210	67	26	stabilization	stabilization	NOUN
dpc-5210	67	27	.	.	PUNCT
dpc-5210	68	1	at	at	ADP
dpc-5210	68	2	1	1	NUM
dpc-5210	68	3	-	-	PUNCT
dpc-5210	68	4	year	year	NOUN
dpc-5210	68	5	follow	follow	NOUN
dpc-5210	68	6	-	-	PUNCT
dpc-5210	68	7	up	up	NOUN
dpc-5210	68	8	,	,	PUNCT
dpc-5210	68	9	70	70	NUM
dpc-5210	68	10	patients	patient	NOUN
dpc-5210	68	11	remained	remain	VERB
dpc-5210	68	12	in	in	ADP
dpc-5210	68	13	group	group	NOUN
dpc-5210	68	14	1	1	NUM
dpc-5210	68	15	,	,	PUNCT
dpc-5210	68	16	and	and	CCONJ
dpc-5210	68	17	11	11	NUM
dpc-5210	68	18	(	(	PUNCT
dpc-5210	68	19	10.89	10.89	NUM
dpc-5210	68	20	%	%	NOUN
dpc-5210	68	21	)	)	PUNCT
dpc-5210	68	22	patients	patient	NOUN
dpc-5210	68	23	experienced	experience	VERB
dpc-5210	68	24	disease	disease	NOUN
dpc-5210	68	25	reactivation	reactivation	NOUN
dpc-5210	68	26	.	.	PUNCT
dpc-5210	69	1	to	to	PART
dpc-5210	69	2	summarize	summarize	VERB
dpc-5210	69	3	,	,	PUNCT
dpc-5210	69	4	108	108	NUM
dpc-5210	69	5	(	(	PUNCT
dpc-5210	69	6	101	101	NUM
dpc-5210	69	7	+	+	NOUN
dpc-5210	69	8	7	7	NUM
dpc-5210	69	9	;	;	PUNCT
dpc-5210	69	10	67.92	67.92	NUM
dpc-5210	69	11	%	%	NOUN
dpc-5210	69	12	)	)	PUNCT
dpc-5210	69	13	patients	patient	NOUN
dpc-5210	69	14	had	have	VERB
dpc-5210	69	15	their	their	PRON
dpc-5210	69	16	active	active	ADJ
dpc-5210	69	17	vitiligo	vitiligo	NOUN
dpc-5210	69	18	stabilized	stabilize	VERB
dpc-5210	69	19	at	at	ADP
dpc-5210	69	20	month	month	NOUN
dpc-5210	69	21	3	3	NUM
dpc-5210	69	22	,	,	PUNCT
dpc-5210	69	23	and	and	CCONJ
dpc-5210	69	24	101	101	NUM
dpc-5210	69	25	(	(	PUNCT
dpc-5210	69	26	63.52	63.52	NUM
dpc-5210	69	27	%	%	NOUN
dpc-5210	69	28	)	)	PUNCT
dpc-5210	69	29	patients	patient	NOUN
dpc-5210	69	30	remained	remain	VERB
dpc-5210	69	31	inactive	inactive	ADJ
dpc-5210	69	32	at	at	ADP
dpc-5210	69	33	month	month	NOUN
dpc-5210	69	34	6	6	NUM
dpc-5210	69	35	from	from	ADP
dpc-5210	69	36	treatment	treatment	NOUN
dpc-5210	69	37	initiation	initiation	NOUN
dpc-5210	69	38	.	.	PUNCT
dpc-5210	70	1	at	at	ADV
dpc-5210	70	2	least	least	ADJ
dpc-5210	70	3	69	69	NUM
dpc-5210	70	4	(	(	PUNCT
dpc-5210	70	5	51	51	NUM
dpc-5210	70	6	+	+	NOUN
dpc-5210	70	7	7	7	NUM
dpc-5210	70	8	+	+	NOUN
dpc-5210	70	9	11	11	NUM
dpc-5210	70	10	;	;	PUNCT
dpc-5210	70	11	43.4	43.4	NUM
dpc-5210	70	12	%	%	NOUN
dpc-5210	70	13	)	)	PUNCT
dpc-5210	70	14	patients	patient	NOUN
dpc-5210	70	15	required	require	VERB
dpc-5210	70	16	extended	extended	ADJ
dpc-5210	70	17	or	or	CCONJ
dpc-5210	70	18	additional	additional	ADJ
dpc-5210	70	19	systemic	systemic	ADJ
dpc-5210	70	20	treatment	treatment	NOUN
dpc-5210	70	21	at	at	ADP
dpc-5210	70	22	1	1	NUM
dpc-5210	70	23	-	-	PUNCT
dpc-5210	70	24	year	year	NOUN
dpc-5210	70	25	follow	follow	NOUN
dpc-5210	70	26	-	-	PUNCT
dpc-5210	70	27	up	up	NOUN
dpc-5210	70	28	from	from	ADP
dpc-5210	70	29	treatment	treatment	NOUN
dpc-5210	70	30	initiation	initiation	NOUN
dpc-5210	70	31	.	.	PUNCT
dpc-5210	71	1	patients	patient	NOUN
dpc-5210	71	2	experiencing	experience	VERB
dpc-5210	71	3	disease	disease	NOUN
dpc-5210	71	4	reactivation	reactivation	NOUN
dpc-5210	71	5	despite	despite	SCONJ
dpc-5210	71	6	initial	initial	ADJ
dpc-5210	71	7	stabilization	stabilization	NOUN
dpc-5210	71	8	were	be	AUX
dpc-5210	71	9	significantly	significantly	ADV
dpc-5210	71	10	younger	young	ADJ
dpc-5210	71	11	(	(	PUNCT
dpc-5210	71	12	39.8±11.39	39.8±11.39	NOUN
dpc-5210	71	13	vs.	vs.	ADP
dpc-5210	71	14	44.85≤14.32	44.85≤14.32	NUM
dpc-5210	71	15	years	year	NOUN
dpc-5210	71	16	;	;	PUNCT
dpc-5210	71	17	p=0.03	p=0.03	X
dpc-5210	71	18	)	)	PUNCT
dpc-5210	71	19	and	and	CCONJ
dpc-5210	71	20	were	be	AUX
dpc-5210	71	21	more	more	ADV
dpc-5210	71	22	likely	likely	ADJ
dpc-5210	71	23	to	to	PART
dpc-5210	71	24	have	have	VERB
dpc-5210	71	25	lesions	lesion	NOUN
dpc-5210	71	26	involving	involve	VERB
dpc-5210	71	27	the	the	DET
dpc-5210	71	28	upper	upper	ADJ
dpc-5210	71	29	limbs	limb	NOUN
dpc-5210	71	30	(	(	PUNCT
dpc-5210	71	31	68.12	68.12	NUM
dpc-5210	71	32	%	%	NOUN
dpc-5210	71	33	vs.	vs.	ADP
dpc-5210	71	34	49.15	49.15	NUM
dpc-5210	71	35	%	%	NOUN
dpc-5210	71	36	;	;	PUNCT
dpc-5210	71	37	p=0.046	p=0.046	NUM
dpc-5210	71	38	)	)	PUNCT
dpc-5210	71	39	.	.	PUNCT
dpc-5210	72	1	conclusion	conclusion	NOUN
dpc-5210	72	2	patients	patient	NOUN
dpc-5210	72	3	with	with	ADP
dpc-5210	72	4	actively	actively	ADV
dpc-5210	72	5	progressing	progress	VERB
dpc-5210	72	6	vitiligo	vitiligo	NOUN
dpc-5210	72	7	often	often	ADV
dpc-5210	72	8	require	require	VERB
dpc-5210	72	9	systemic	systemic	ADJ
dpc-5210	72	10	treatments	treatment	NOUN
dpc-5210	72	11	in	in	ADP
dpc-5210	72	12	addition	addition	NOUN
dpc-5210	72	13	to	to	ADP
dpc-5210	72	14	phototherapy	phototherapy	NOUN
dpc-5210	72	15	to	to	PART
dpc-5210	72	16	achieve	achieve	VERB
dpc-5210	72	17	good	good	ADJ
dpc-5210	72	18	disease	disease	NOUN
dpc-5210	72	19	stabilization	stabilization	NOUN
dpc-5210	72	20	and	and	CCONJ
dpc-5210	72	21	induce	induce	VERB
dpc-5210	72	22	repigmentation	repigmentation	NOUN
dpc-5210	72	23	.	.	PUNCT
dpc-5210	73	1	there	there	PRON
dpc-5210	73	2	remains	remain	VERB
dpc-5210	73	3	no	no	DET
dpc-5210	73	4	standard	standard	ADJ
dpc-5210	73	5	systemic	systemic	ADJ
dpc-5210	73	6	treatment	treatment	NOUN
dpc-5210	73	7	for	for	ADP
dpc-5210	73	8	active	active	ADJ
dpc-5210	73	9	vitiligo	vitiligo	NOUN
dpc-5210	73	10	.	.	PUNCT
dpc-5210	74	1	however	however	ADV
dpc-5210	74	2	,	,	PUNCT
dpc-5210	74	3	mini	mini	ADJ
dpc-5210	74	4	-	-	NOUN
dpc-5210	74	5	pulse	pulse	ADJ
dpc-5210	74	6	therapy	therapy	NOUN
dpc-5210	74	7	with	with	ADP
dpc-5210	74	8	oral	oral	ADJ
dpc-5210	74	9	dexamethasone	dexamethasone	NOUN
dpc-5210	74	10	and	and	CCONJ
dpc-5210	74	11	low	low	ADV
dpc-5210	74	12	-	-	PUNCT
dpc-5210	74	13	dose	dose	NOUN
dpc-5210	74	14	methotrexate	methotrexate	NOUN
dpc-5210	74	15	have	have	AUX
dpc-5210	74	16	been	be	AUX
dpc-5210	74	17	demonstrated	demonstrate	VERB
dpc-5210	74	18	to	to	PART
dpc-5210	74	19	provide	provide	VERB
dpc-5210	74	20	good	good	ADJ
dpc-5210	74	21	disease	disease	NOUN
dpc-5210	74	22	control	control	NOUN
dpc-5210	74	23	with	with	ADP
dpc-5210	74	24	minimal	minimal	ADJ
dpc-5210	74	25	adverse	adverse	ADJ
dpc-5210	74	26	events	event	NOUN
dpc-5210	74	27	in	in	ADP
dpc-5210	74	28	active	active	ADJ
dpc-5210	74	29	vitiligo	vitiligo	NOUN
dpc-5210	74	30	patients	patient	NOUN
dpc-5210	74	31	[	[	X
dpc-5210	74	32	5,6,12	5,6,12	NUM
dpc-5210	74	33	]	]	PUNCT
dpc-5210	74	34	.	.	PUNCT
dpc-5210	75	1	currently	currently	ADV
dpc-5210	75	2	,	,	PUNCT
dpc-5210	75	3	the	the	DET
dpc-5210	75	4	recommended	recommend	VERB
dpc-5210	75	5	treatment	treatment	NOUN
dpc-5210	75	6	duration	duration	NOUN
dpc-5210	75	7	for	for	ADP
dpc-5210	75	8	these	these	DET
dpc-5210	75	9	systemic	systemic	ADJ
dpc-5210	75	10	immunosuppressants	immunosuppressant	NOUN
dpc-5210	75	11	is	be	AUX
dpc-5210	75	12	three	three	NUM
dpc-5210	75	13	to	to	PART
dpc-5210	75	14	six	six	NUM
dpc-5210	75	15	months	month	NOUN
dpc-5210	76	1	[	[	X
dpc-5210	76	2	3,4	3,4	NUM
dpc-5210	76	3	]	]	PUNCT
dpc-5210	76	4	.	.	PUNCT
dpc-5210	77	1	nevertheless	nevertheless	ADV
dpc-5210	77	2	,	,	PUNCT
dpc-5210	77	3	the	the	DET
dpc-5210	77	4	clinical	clinical	ADJ
dpc-5210	77	5	profiles	profile	NOUN
dpc-5210	77	6	of	of	ADP
dpc-5210	77	7	difficult	difficult	ADJ
dpc-5210	77	8	-	-	PUNCT
dpc-5210	77	9	to	to	ADP
dpc-5210	77	10	-	-	PUNCT
dpc-5210	77	11	control	control	NOUN
dpc-5210	77	12	patients	patient	NOUN
dpc-5210	77	13	and	and	CCONJ
dpc-5210	77	14	the	the	DET
dpc-5210	77	15	likelihood	likelihood	NOUN
dpc-5210	77	16	of	of	ADP
dpc-5210	77	17	recurrence	recurrence	NOUN
dpc-5210	77	18	once	once	SCONJ
dpc-5210	77	19	stabilization	stabilization	NOUN
dpc-5210	77	20	has	have	AUX
dpc-5210	77	21	been	be	AUX
dpc-5210	77	22	achieved	achieve	VERB
dpc-5210	77	23	have	have	AUX
dpc-5210	77	24	not	not	PART
dpc-5210	77	25	been	be	AUX
dpc-5210	77	26	well	well	ADV
dpc-5210	77	27	-	-	PUNCT
dpc-5210	77	28	documented	document	VERB
dpc-5210	77	29	.	.	PUNCT
dpc-5210	78	1	in	in	ADP
dpc-5210	78	2	the	the	DET
dpc-5210	78	3	present	present	ADJ
dpc-5210	78	4	study	study	NOUN
dpc-5210	78	5	,	,	PUNCT
dpc-5210	78	6	both	both	CCONJ
dpc-5210	78	7	univariate	univariate	ADJ
dpc-5210	78	8	and	and	CCONJ
dpc-5210	78	9	multivariate	multivariate	NOUN
dpc-5210	78	10	analyses	analysis	NOUN
dpc-5210	78	11	showed	show	VERB
dpc-5210	78	12	that	that	SCONJ
dpc-5210	78	13	older	old	ADJ
dpc-5210	78	14	patients	patient	NOUN
dpc-5210	78	15	and	and	CCONJ
dpc-5210	78	16	patients	patient	NOUN
dpc-5210	78	17	with	with	ADP
dpc-5210	78	18	facial	facial	ADJ
dpc-5210	78	19	table	table	NOUN
dpc-5210	78	20	1	1	NUM
dpc-5210	78	21	.	.	PUNCT
dpc-5210	78	22	patient	patient	ADJ
dpc-5210	78	23	characteristics	characteristic	NOUN
dpc-5210	78	24	.	.	PUNCT
dpc-5210	79	1	group	group	NOUN
dpc-5210	79	2	1	1	NUM
dpc-5210	79	3	group	group	NOUN
dpc-5210	79	4	2	2	NUM
dpc-5210	79	5	group	group	NOUN
dpc-5210	79	6	3	3	NUM
dpc-5210	79	7	n	n	NOUN
dpc-5210	79	8	=	=	SYM
dpc-5210	79	9	101	101	NUM
dpc-5210	79	10	n	n	NOUN
dpc-5210	79	11	=	=	SYM
dpc-5210	79	12	51	51	NUM
dpc-5210	79	13	n	n	NOUN
dpc-5210	79	14	=	=	SYM
dpc-5210	79	15	7	7	NUM
dpc-5210	79	16	p	p	ADJ
dpc-5210	79	17	-	-	PUNCT
dpc-5210	79	18	value	value	NOUN
dpc-5210	79	19	age	age	NOUN
dpc-5210	79	20	,	,	PUNCT
dpc-5210	79	21	mean	mean	NOUN
dpc-5210	79	22	(	(	PUNCT
dpc-5210	79	23	sd	sd	NOUN
dpc-5210	79	24	)	)	PUNCT
dpc-5210	79	25	46.47	46.47	NUM
dpc-5210	79	26	(	(	PUNCT
dpc-5210	79	27	14.91	14.91	NUM
dpc-5210	79	28	)	)	PUNCT
dpc-5210	79	29	39.69	39.69	NUM
dpc-5210	79	30	(	(	PUNCT
dpc-5210	79	31	11.51	11.51	NUM
dpc-5210	79	32	)	)	PUNCT
dpc-5210	79	33	40.71	40.71	NUM
dpc-5210	79	34	(	(	PUNCT
dpc-5210	79	35	9.46	9.46	NUM
dpc-5210	79	36	)	)	PUNCT
dpc-5210	79	37	0.02	0.02	NUM
dpc-5210	79	38	sex	sex	NOUN
dpc-5210	79	39	(	(	PUNCT
dpc-5210	79	40	female	female	NOUN
dpc-5210	79	41	)	)	PUNCT
dpc-5210	79	42	61	61	NUM
dpc-5210	79	43	(	(	PUNCT
dpc-5210	79	44	60.40	60.40	NUM
dpc-5210	79	45	%	%	NOUN
dpc-5210	79	46	)	)	PUNCT
dpc-5210	79	47	28	28	NUM
dpc-5210	79	48	(	(	PUNCT
dpc-5210	79	49	54.90	54.90	NUM
dpc-5210	79	50	%	%	NOUN
dpc-5210	79	51	)	)	PUNCT
dpc-5210	79	52	5	5	NUM
dpc-5210	79	53	(	(	PUNCT
dpc-5210	79	54	71.43	71.43	NUM
dpc-5210	79	55	%	%	NOUN
dpc-5210	79	56	)	)	PUNCT
dpc-5210	79	57	0.71	0.71	NUM
dpc-5210	79	58	positive	positive	ADJ
dpc-5210	79	59	family	family	NOUN
dpc-5210	79	60	history	history	NOUN
dpc-5210	79	61	of	of	ADP
dpc-5210	79	62	vitiligo	vitiligo	NOUN
dpc-5210	79	63	4	4	NUM
dpc-5210	79	64	(	(	PUNCT
dpc-5210	79	65	3.96	3.96	NUM
dpc-5210	79	66	%	%	NOUN
dpc-5210	79	67	)	)	PUNCT
dpc-5210	79	68	4	4	NUM
dpc-5210	79	69	(	(	PUNCT
dpc-5210	79	70	7.84	7.84	NUM
dpc-5210	79	71	%	%	NOUN
dpc-5210	79	72	)	)	PUNCT
dpc-5210	79	73	0	0	NUM
dpc-5210	80	1	(	(	PUNCT
dpc-5210	80	2	0	0	NUM
dpc-5210	80	3	%	%	NOUN
dpc-5210	80	4	)	)	PUNCT
dpc-5210	80	5	0.61	0.61	NUM
dpc-5210	80	6	positive	positive	ADJ
dpc-5210	80	7	family	family	NOUN
dpc-5210	80	8	history	history	NOUN
dpc-5210	80	9	of	of	ADP
dpc-5210	80	10	thyroid	thyroid	NOUN
dpc-5210	80	11	disease	disease	NOUN
dpc-5210	80	12	11	11	NUM
dpc-5210	80	13	(	(	PUNCT
dpc-5210	80	14	10.89	10.89	NUM
dpc-5210	80	15	%	%	NOUN
dpc-5210	80	16	)	)	PUNCT
dpc-5210	80	17	4	4	NUM
dpc-5210	80	18	(	(	PUNCT
dpc-5210	80	19	7.84	7.84	NUM
dpc-5210	80	20	%	%	NOUN
dpc-5210	80	21	)	)	PUNCT
dpc-5210	80	22	2	2	NUM
dpc-5210	80	23	(	(	PUNCT
dpc-5210	80	24	28.57	28.57	NUM
dpc-5210	80	25	%	%	NOUN
dpc-5210	80	26	)	)	PUNCT
dpc-5210	80	27	0.21	0.21	NUM
dpc-5210	80	28	abnormal	abnormal	ADJ
dpc-5210	80	29	thyroid	thyroid	NOUN
dpc-5210	80	30	tests	test	VERB
dpc-5210	80	31	29	29	NUM
dpc-5210	80	32	(	(	PUNCT
dpc-5210	80	33	28.71	28.71	NUM
dpc-5210	80	34	%	%	NOUN
dpc-5210	80	35	)	)	PUNCT
dpc-5210	80	36	14	14	NUM
dpc-5210	80	37	(	(	PUNCT
dpc-5210	80	38	27.45	27.45	NUM
dpc-5210	80	39	%	%	NOUN
dpc-5210	80	40	)	)	PUNCT
dpc-5210	80	41	3	3	NUM
dpc-5210	80	42	(	(	PUNCT
dpc-5210	80	43	42.86	42.86	NUM
dpc-5210	80	44	%	%	NOUN
dpc-5210	80	45	)	)	PUNCT
dpc-5210	80	46	0.71	0.71	NUM
dpc-5210	80	47	abnormal	abnormal	ADJ
dpc-5210	80	48	ana	ana	PROPN
dpc-5210	80	49	8	8	NUM
dpc-5210	80	50	(	(	PUNCT
dpc-5210	80	51	7.92	7.92	NUM
dpc-5210	80	52	%	%	NOUN
dpc-5210	80	53	)	)	PUNCT
dpc-5210	80	54	3	3	NUM
dpc-5210	80	55	(	(	PUNCT
dpc-5210	80	56	5.88	5.88	NUM
dpc-5210	80	57	%	%	NOUN
dpc-5210	80	58	)	)	PUNCT
dpc-5210	80	59	0	0	NUM
dpc-5210	81	1	(	(	PUNCT
dpc-5210	81	2	0	0	NUM
dpc-5210	81	3	%	%	NOUN
dpc-5210	81	4	)	)	PUNCT
dpc-5210	81	5	1	1	NUM
dpc-5210	81	6	concomitant	concomitant	ADJ
dpc-5210	81	7	autoimmune	autoimmune	ADJ
dpc-5210	81	8	disease	disease	NOUN
dpc-5210	81	9	6	6	NUM
dpc-5210	81	10	(	(	PUNCT
dpc-5210	81	11	5.94	5.94	NUM
dpc-5210	81	12	%	%	NOUN
dpc-5210	81	13	)	)	PUNCT
dpc-5210	81	14	2	2	NUM
dpc-5210	81	15	(	(	PUNCT
dpc-5210	81	16	3.92	3.92	NUM
dpc-5210	81	17	%	%	NOUN
dpc-5210	81	18	)	)	PUNCT
dpc-5210	81	19	0	0	NUM
dpc-5210	82	1	(	(	PUNCT
dpc-5210	82	2	0	0	NUM
dpc-5210	82	3	%	%	NOUN
dpc-5210	82	4	)	)	PUNCT
dpc-5210	82	5	1	1	NUM
dpc-5210	82	6	anatomic	anatomic	ADJ
dpc-5210	82	7	location	location	NOUN
dpc-5210	82	8	face	face	NOUN
dpc-5210	82	9	77	77	NUM
dpc-5210	82	10	(	(	PUNCT
dpc-5210	82	11	76.24	76.24	NUM
dpc-5210	82	12	%	%	NOUN
dpc-5210	82	13	)	)	PUNCT
dpc-5210	82	14	29	29	NUM
dpc-5210	82	15	(	(	PUNCT
dpc-5210	82	16	56.86	56.86	NUM
dpc-5210	82	17	%	%	NOUN
dpc-5210	82	18	)	)	PUNCT
dpc-5210	82	19	6	6	NUM
dpc-5210	82	20	(	(	PUNCT
dpc-5210	82	21	85.71	85.71	NUM
dpc-5210	82	22	%	%	NOUN
dpc-5210	82	23	)	)	PUNCT
dpc-5210	82	24	0.03	0.03	NUM
dpc-5210	82	25	neck	neck	NOUN
dpc-5210	82	26	36	36	NUM
dpc-5210	82	27	(	(	PUNCT
dpc-5210	82	28	35.64	35.64	NUM
dpc-5210	82	29	%	%	NOUN
dpc-5210	82	30	)	)	PUNCT
dpc-5210	82	31	16	16	NUM
dpc-5210	82	32	(	(	PUNCT
dpc-5210	82	33	31.37	31.37	NUM
dpc-5210	82	34	%	%	NOUN
dpc-5210	82	35	)	)	PUNCT
dpc-5210	82	36	1	1	NUM
dpc-5210	82	37	(	(	PUNCT
dpc-5210	82	38	14.29	14.29	NUM
dpc-5210	82	39	%	%	NOUN
dpc-5210	82	40	)	)	PUNCT
dpc-5210	82	41	0.55	0.55	NUM
dpc-5210	82	42	trunk	trunk	NOUN
dpc-5210	82	43	40	40	NUM
dpc-5210	82	44	(	(	PUNCT
dpc-5210	82	45	39.60	39.60	NUM
dpc-5210	82	46	%	%	NOUN
dpc-5210	82	47	)	)	PUNCT
dpc-5210	82	48	27	27	NUM
dpc-5210	82	49	(	(	PUNCT
dpc-5210	82	50	52.94	52.94	NUM
dpc-5210	82	51	%	%	NOUN
dpc-5210	82	52	)	)	PUNCT
dpc-5210	82	53	5	5	NUM
dpc-5210	82	54	(	(	PUNCT
dpc-5210	82	55	71.43	71.43	NUM
dpc-5210	82	56	%	%	NOUN
dpc-5210	82	57	)	)	PUNCT
dpc-5210	82	58	0.11	0.11	NUM
dpc-5210	82	59	upper	upper	ADJ
dpc-5210	82	60	limbs	limb	NOUN
dpc-5210	82	61	52	52	NUM
dpc-5210	82	62	(	(	PUNCT
dpc-5210	82	63	51.49	51.49	NUM
dpc-5210	82	64	%	%	NOUN
dpc-5210	82	65	)	)	PUNCT
dpc-5210	82	66	34	34	NUM
dpc-5210	82	67	(	(	PUNCT
dpc-5210	82	68	66.66	66.66	NUM
dpc-5210	82	69	%	%	NOUN
dpc-5210	82	70	)	)	PUNCT
dpc-5210	82	71	5	5	NUM
dpc-5210	82	72	(	(	PUNCT
dpc-5210	82	73	71.43	71.43	NUM
dpc-5210	82	74	%	%	NOUN
dpc-5210	82	75	)	)	PUNCT
dpc-5210	82	76	0.14	0.14	NUM
dpc-5210	82	77	hands	hand	NOUN
dpc-5210	82	78	40	40	NUM
dpc-5210	82	79	(	(	PUNCT
dpc-5210	82	80	39.60	39.60	NUM
dpc-5210	82	81	%	%	NOUN
dpc-5210	82	82	)	)	PUNCT
dpc-5210	82	83	26	26	NUM
dpc-5210	82	84	(	(	PUNCT
dpc-5210	82	85	50.98	50.98	NUM
dpc-5210	82	86	%	%	NOUN
dpc-5210	82	87	)	)	PUNCT
dpc-5210	82	88	2	2	NUM
dpc-5210	82	89	(	(	PUNCT
dpc-5210	82	90	28.57	28.57	NUM
dpc-5210	82	91	%	%	NOUN
dpc-5210	82	92	)	)	PUNCT
dpc-5210	82	93	0.34	0.34	NUM
dpc-5210	82	94	lower	low	ADJ
dpc-5210	82	95	limbs	limb	NOUN
dpc-5210	82	96	26	26	NUM
dpc-5210	82	97	(	(	PUNCT
dpc-5210	82	98	25.74	25.74	NUM
dpc-5210	82	99	%	%	NOUN
dpc-5210	82	100	)	)	PUNCT
dpc-5210	82	101	21	21	NUM
dpc-5210	82	102	(	(	PUNCT
dpc-5210	82	103	41.18	41.18	NUM
dpc-5210	82	104	%	%	NOUN
dpc-5210	82	105	)	)	PUNCT
dpc-5210	82	106	3	3	NUM
dpc-5210	82	107	(	(	PUNCT
dpc-5210	82	108	42.86	42.86	NUM
dpc-5210	82	109	%	%	NOUN
dpc-5210	82	110	)	)	PUNCT
dpc-5210	82	111	0.11	0.11	NUM
dpc-5210	82	112	bold	bold	ADJ
dpc-5210	82	113	numbers	number	NOUN
dpc-5210	82	114	indicate	indicate	VERB
dpc-5210	82	115	p<0.05	p<0.05	NOUN
dpc-5210	82	116	.	.	PUNCT
dpc-5210	83	1	abnormal	abnormal	ADJ
dpc-5210	83	2	ana	ana	PROPN
dpc-5210	83	3	test	test	NOUN
dpc-5210	83	4	was	be	AUX
dpc-5210	83	5	defined	define	VERB
dpc-5210	83	6	as	as	ADP
dpc-5210	83	7	ana	ana	PROPN
dpc-5210	83	8	titer	titer	NOUN
dpc-5210	83	9	>	>	PROPN
dpc-5210	83	10	1:80	1:80	NUM
dpc-5210	83	11	.	.	PUNCT
dpc-5210	84	1	abbreviations	abbreviation	NOUN
dpc-5210	84	2	:	:	PUNCT
dpc-5210	85	1	ana	ana	PROPN
dpc-5210	85	2	:	:	PUNCT
dpc-5210	85	3	antinuclear	antinuclear	ADJ
dpc-5210	85	4	antibody	antibody	NOUN
dpc-5210	85	5	;	;	PUNCT
dpc-5210	85	6	sd	sd	X
dpc-5210	85	7	:	:	PUNCT
dpc-5210	85	8	standard	standard	ADJ
dpc-5210	85	9	deviation	deviation	NOUN
dpc-5210	85	10	.	.	PUNCT
dpc-5210	86	1	4	4	NUM
dpc-5210	86	2	original	original	ADJ
dpc-5210	86	3	article	article	NOUN
dpc-5210	86	4	|	|	ADV
dpc-5210	86	5	dermatol	dermatol	ADJ
dpc-5210	86	6	pract	pract	NOUN
dpc-5210	86	7	concept	concept	NOUN
dpc-5210	86	8	.	.	PUNCT
dpc-5210	87	1	2025;15(4):5210	2025;15(4):5210	PROPN
dpc-5210	87	2	repigmentation	repigmentation	VERB
dpc-5210	87	3	[	[	X
dpc-5210	87	4	16	16	NUM
dpc-5210	87	5	]	]	X
dpc-5210	87	6	is	be	AUX
dpc-5210	87	7	often	often	ADV
dpc-5210	87	8	observed	observe	VERB
dpc-5210	87	9	among	among	ADP
dpc-5210	87	10	different	different	ADJ
dpc-5210	87	11	vitiligo	vitiligo	NOUN
dpc-5210	87	12	lesions	lesion	NOUN
dpc-5210	87	13	,	,	PUNCT
dpc-5210	87	14	careful	careful	ADJ
dpc-5210	87	15	photo	photo	NOUN
dpc-5210	87	16	documentation	documentation	NOUN
dpc-5210	87	17	is	be	AUX
dpc-5210	87	18	essential	essential	ADJ
dpc-5210	87	19	to	to	ADP
dpc-5210	87	20	optimal	optimal	ADJ
dpc-5210	87	21	vitiligo	vitiligo	NOUN
dpc-5210	87	22	management	management	NOUN
dpc-5210	87	23	so	so	SCONJ
dpc-5210	87	24	that	that	SCONJ
dpc-5210	87	25	immunosuppressants	immunosuppressant	NOUN
dpc-5210	87	26	may	may	AUX
dpc-5210	87	27	be	be	AUX
dpc-5210	87	28	given	give	VERB
dpc-5210	87	29	promptly	promptly	ADV
dpc-5210	87	30	when	when	SCONJ
dpc-5210	87	31	disease	disease	NOUN
dpc-5210	87	32	activity	activity	NOUN
dpc-5210	87	33	flare	flare	NOUN
dpc-5210	87	34	occurs	occur	VERB
dpc-5210	87	35	after	after	ADP
dpc-5210	87	36	initial	initial	ADJ
dpc-5210	87	37	stabilization	stabilization	NOUN
dpc-5210	87	38	.	.	PUNCT
dpc-5210	88	1	ethical	ethical	ADJ
dpc-5210	88	2	approval	approval	NOUN
dpc-5210	88	3	:	:	PUNCT
dpc-5210	88	4	this	this	DET
dpc-5210	88	5	study	study	NOUN
dpc-5210	88	6	was	be	AUX
dpc-5210	88	7	approved	approve	VERB
dpc-5210	88	8	by	by	ADP
dpc-5210	88	9	the	the	DET
dpc-5210	88	10	hospital	hospital	NOUN
dpc-5210	88	11	institutional	institutional	PROPN
dpc-5210	88	12	review	review	PROPN
dpc-5210	88	13	board	board	NOUN
dpc-5210	88	14	(	(	PUNCT
dpc-5210	88	15	kmuhirb	kmuhirb	PROPN
dpc-5210	88	16	-	-	PUNCT
dpc-5210	88	17	e(i)-20240106	e(i)-20240106	NOUN
dpc-5210	88	18	)	)	PUNCT
dpc-5210	88	19	.	.	PUNCT
dpc-5210	89	1	references	reference	NOUN
dpc-5210	89	2	1	1	NUM
dpc-5210	89	3	.	.	PUNCT
dpc-5210	89	4	ezzedine	ezzedine	PROPN
dpc-5210	90	1	k	k	PROPN
dpc-5210	90	2	,	,	PUNCT
dpc-5210	90	3	harris	harris	PROPN
dpc-5210	90	4	je	je	PROPN
dpc-5210	90	5	.	.	PUNCT
dpc-5210	90	6	vitiligo	vitiligo	VERB
dpc-5210	90	7	.	.	PUNCT
dpc-5210	91	1	in	in	ADP
dpc-5210	91	2	:	:	PUNCT
dpc-5210	91	3	kang	kang	PROPN
dpc-5210	91	4	s	s	PROPN
dpc-5210	91	5	,	,	PUNCT
dpc-5210	91	6	amagai	amagai	PROPN
dpc-5210	91	7	m	m	PROPN
dpc-5210	91	8	,	,	PUNCT
dpc-5210	91	9	bruckner	bruckner	PROPN
dpc-5210	91	10	al	al	PROPN
dpc-5210	91	11	,	,	PUNCT
dpc-5210	91	12	et	et	PROPN
dpc-5210	91	13	al	al	PROPN
dpc-5210	91	14	.	.	PROPN
dpc-5210	91	15	,	,	PUNCT
dpc-5210	91	16	eds	eds	PROPN
dpc-5210	91	17	.	.	PUNCT
dpc-5210	92	1	fitzpatrick	fitzpatrick	PROPN
dpc-5210	92	2	’s	’s	PART
dpc-5210	92	3	dermatology	dermatology	NOUN
dpc-5210	92	4	,	,	PUNCT
dpc-5210	92	5	9e	9e	NUM
dpc-5210	92	6	.	.	PUNCT
dpc-5210	93	1	mcgraw	mcgraw	PROPN
dpc-5210	93	2	-	-	PUNCT
dpc-5210	93	3	hill	hill	NOUN
dpc-5210	93	4	education	education	NOUN
dpc-5210	93	5	;	;	PUNCT
dpc-5210	93	6	2019	2019	NUM
dpc-5210	93	7	.	.	PUNCT
dpc-5210	94	1	accessed	access	VERB
dpc-5210	94	2	january	january	PROPN
dpc-5210	94	3	15	15	NUM
dpc-5210	94	4	,	,	PUNCT
dpc-5210	94	5	2024	2024	NUM
dpc-5210	94	6	.	.	PUNCT
dpc-5210	95	1	accessmedicine.mhmedical.com/content.aspx?aid=1161324334	accessmedicine.mhmedical.com/content.aspx?aid=1161324334	NOUN
dpc-5210	95	2	2	2	NUM
dpc-5210	95	3	.	.	PUNCT
dpc-5210	96	1	yang	yang	PROPN
dpc-5210	96	2	tt	tt	PROPN
dpc-5210	96	3	,	,	PUNCT
dpc-5210	96	4	lee	lee	PROPN
dpc-5210	96	5	ch	ch	PROPN
dpc-5210	96	6	,	,	PUNCT
dpc-5210	96	7	lan	lan	PROPN
dpc-5210	96	8	cce	cce	PROPN
dpc-5210	96	9	.	.	PROPN
dpc-5210	96	10	impact	impact	NOUN
dpc-5210	96	11	of	of	ADP
dpc-5210	96	12	vitiligo	vitiligo	NOUN
dpc-5210	96	13	on	on	ADP
dpc-5210	96	14	life	life	NOUN
dpc-5210	96	15	quality	quality	NOUN
dpc-5210	96	16	of	of	ADP
dpc-5210	96	17	patients	patient	NOUN
dpc-5210	96	18	:	:	PUNCT
dpc-5210	96	19	assessment	assessment	NOUN
dpc-5210	96	20	of	of	ADP
dpc-5210	96	21	currently	currently	ADV
dpc-5210	96	22	available	available	ADJ
dpc-5210	96	23	tools	tool	NOUN
dpc-5210	96	24	.	.	PUNCT
dpc-5210	97	1	int	int	PROPN
dpc-5210	97	2	j	j	PROPN
dpc-5210	97	3	environ	environ	PROPN
dpc-5210	97	4	res	re	VERB
dpc-5210	97	5	public	public	ADJ
dpc-5210	97	6	health	health	NOUN
dpc-5210	97	7	.	.	PUNCT
dpc-5210	98	1	2022;19(22):14943	2022;19(22):14943	X
dpc-5210	98	2	.	.	PUNCT
dpc-5210	98	3	doi:10.3390	doi:10.3390	NOUN
dpc-5210	98	4	/ijerph192214943	/ijerph192214943	PUNCT
dpc-5210	98	5	.	.	PUNCT
dpc-5210	99	1	pmid	pmid	NOUN
dpc-5210	99	2	:	:	PUNCT
dpc-5210	99	3	36429664	36429664	NUM
dpc-5210	99	4	.	.	PUNCT
dpc-5210	100	1	3	3	X
dpc-5210	100	2	.	.	X
dpc-5210	100	3	böhm	böhm	PROPN
dpc-5210	100	4	m	m	PROPN
dpc-5210	100	5	,	,	PUNCT
dpc-5210	100	6	schunter	schunter	VERB
dpc-5210	100	7	ja	ja	PROPN
dpc-5210	100	8	,	,	PUNCT
dpc-5210	100	9	fritz	fritz	PROPN
dpc-5210	100	10	k	k	PROPN
dpc-5210	100	11	,	,	PUNCT
dpc-5210	100	12	et	et	PROPN
dpc-5210	100	13	al	al	PROPN
dpc-5210	100	14	.	.	PUNCT
dpc-5210	101	1	s1	s1	PROPN
dpc-5210	101	2	guideline	guideline	NOUN
dpc-5210	101	3	:	:	PUNCT
dpc-5210	101	4	diagnosis	diagnosis	NOUN
dpc-5210	101	5	and	and	CCONJ
dpc-5210	101	6	therapy	therapy	NOUN
dpc-5210	101	7	of	of	ADP
dpc-5210	101	8	vitiligo	vitiligo	PROPN
dpc-5210	101	9	.	.	PUNCT
dpc-5210	102	1	jddg	jddg	PROPN
dpc-5210	102	2	j	j	PROPN
dpc-5210	102	3	dtsch	dtsch	PROPN
dpc-5210	102	4	dermatol	dermatol	NOUN
dpc-5210	102	5	ges	ge	NOUN
dpc-5210	102	6	.	.	PROPN
dpc-5210	102	7	2022;20(3):365	2022;20(3):365	PROPN
dpc-5210	102	8	-	-	PUNCT
dpc-5210	102	9	378	378	NUM
dpc-5210	102	10	.	.	PUNCT
dpc-5210	103	1	doi:10.1111	doi:10.1111	NOUN
dpc-5210	103	2	/	/	SYM
dpc-5210	103	3	ddg.14713	ddg.14713	ADP
dpc-5210	103	4	4	4	NUM
dpc-5210	103	5	.	.	PUNCT
dpc-5210	104	1	eleftheriadou	eleftheriadou	PROPN
dpc-5210	104	2	v	v	PROPN
dpc-5210	104	3	,	,	PUNCT
dpc-5210	104	4	atkar	atkar	PROPN
dpc-5210	104	5	r	r	PROPN
dpc-5210	104	6	,	,	PUNCT
dpc-5210	104	7	batchelor	batchelor	PROPN
dpc-5210	104	8	j	j	PROPN
dpc-5210	104	9	,	,	PUNCT
dpc-5210	104	10	et	et	PROPN
dpc-5210	104	11	al	al	PROPN
dpc-5210	104	12	.	.	PROPN
dpc-5210	105	1	british	british	PROPN
dpc-5210	105	2	association	association	PROPN
dpc-5210	105	3	of	of	ADP
dpc-5210	105	4	dermatologists	dermatologists	PROPN
dpc-5210	105	5	guidelines	guideline	NOUN
dpc-5210	105	6	for	for	ADP
dpc-5210	105	7	the	the	DET
dpc-5210	105	8	management	management	NOUN
dpc-5210	105	9	of	of	ADP
dpc-5210	105	10	people	people	NOUN
dpc-5210	105	11	with	with	ADP
dpc-5210	105	12	vitiligo	vitiligo	NOUN
dpc-5210	105	13	2021	2021	NUM
dpc-5210	105	14	.	.	PUNCT
dpc-5210	106	1	br	br	PROPN
dpc-5210	106	2	j	j	PROPN
dpc-5210	106	3	dermatol	dermatol	NOUN
dpc-5210	106	4	.	.	PUNCT
dpc-5210	107	1	2022;186(1):18	2022;186(1):18	PROPN
dpc-5210	107	2	-	-	PUNCT
dpc-5210	107	3	29	29	NUM
dpc-5210	107	4	.	.	PUNCT
dpc-5210	108	1	doi:10.1111	doi:10.1111	PROPN
dpc-5210	108	2	/bjd.20596	/bjd.20596	PROPN
dpc-5210	108	3	.	.	PUNCT
dpc-5210	109	1	pmid	pmid	NOUN
dpc-5210	109	2	:	:	PUNCT
dpc-5210	109	3	34160061	34160061	NUM
dpc-5210	109	4	.	.	PUNCT
dpc-5210	110	1	5	5	X
dpc-5210	110	2	.	.	X
dpc-5210	110	3	singh	singh	PROPN
dpc-5210	110	4	h	h	PROPN
dpc-5210	110	5	,	,	PUNCT
dpc-5210	110	6	kumaran	kumaran	PROPN
dpc-5210	110	7	ms	ms	PROPN
dpc-5210	110	8	,	,	PUNCT
dpc-5210	110	9	bains	bain	NOUN
dpc-5210	110	10	a	a	PRON
dpc-5210	110	11	,	,	PUNCT
dpc-5210	110	12	parsad	parsad	PROPN
dpc-5210	110	13	d.	d.	PROPN
dpc-5210	110	14	a	a	DET
dpc-5210	110	15	randomized	randomized	ADJ
dpc-5210	110	16	comparative	comparative	ADJ
dpc-5210	110	17	study	study	NOUN
dpc-5210	110	18	of	of	ADP
dpc-5210	110	19	oral	oral	ADJ
dpc-5210	110	20	corticosteroid	corticosteroid	ADJ
dpc-5210	110	21	minipulse	minipulse	NOUN
dpc-5210	110	22	and	and	CCONJ
dpc-5210	110	23	lowdose	lowdose	ADJ
dpc-5210	110	24	oral	oral	ADJ
dpc-5210	110	25	methotrexate	methotrexate	NOUN
dpc-5210	110	26	in	in	ADP
dpc-5210	110	27	the	the	DET
dpc-5210	110	28	treatment	treatment	NOUN
dpc-5210	110	29	of	of	ADP
dpc-5210	110	30	unstable	unstable	ADJ
dpc-5210	110	31	vitiligo	vitiligo	NOUN
dpc-5210	110	32	.	.	PUNCT
dpc-5210	111	1	dermatology	dermatology	NOUN
dpc-5210	111	2	.	.	PUNCT
dpc-5210	112	1	2015;231(3):286	2015;231(3):286	NUM
dpc-5210	112	2	-	-	SYM
dpc-5210	112	3	290	290	NUM
dpc-5210	112	4	.	.	PUNCT
dpc-5210	113	1	doi:10.1159/000433424	doi:10.1159/000433424	X
dpc-5210	113	2	.	.	PUNCT
dpc-5210	114	1	pmid	pmid	NOUN
dpc-5210	114	2	:	:	PUNCT
dpc-5210	114	3	26278124	26278124	NUM
dpc-5210	114	4	.	.	PUNCT
dpc-5210	115	1	6	6	NUM
dpc-5210	115	2	.	.	X
dpc-5210	115	3	kanwar	kanwar	PROPN
dpc-5210	115	4	aj	aj	PROPN
dpc-5210	115	5	,	,	PUNCT
dpc-5210	115	6	dhar	dhar	PROPN
dpc-5210	115	7	s	s	PROPN
dpc-5210	115	8	,	,	PUNCT
dpc-5210	115	9	dawn	dawn	PROPN
dpc-5210	115	10	g.	g.	PROPN
dpc-5210	115	11	oral	oral	ADJ
dpc-5210	115	12	minipulse	minipulse	NOUN
dpc-5210	115	13	therapy	therapy	NOUN
dpc-5210	115	14	in	in	ADP
dpc-5210	115	15	vitiligo	vitiligo	PROPN
dpc-5210	115	16	.	.	PUNCT
dpc-5210	116	1	dermatology	dermatology	NOUN
dpc-5210	116	2	.	.	PUNCT
dpc-5210	117	1	1995;190(3):251	1995;190(3):251	NUM
dpc-5210	117	2	-	-	SYM
dpc-5210	117	3	252	252	NUM
dpc-5210	117	4	.	.	PUNCT
dpc-5210	117	5	doi:10.1159/000246705	doi:10.1159/000246705	NOUN
dpc-5210	117	6	.	.	PUNCT
dpc-5210	118	1	pmid	pmid	NOUN
dpc-5210	118	2	:	:	PUNCT
dpc-5210	118	3	7599392	7599392	NUM
dpc-5210	118	4	.	.	PUNCT
dpc-5210	119	1	7	7	X
dpc-5210	119	2	.	.	X
dpc-5210	119	3	lan	lan	PROPN
dpc-5210	119	4	cce	cce	PROPN
dpc-5210	119	5	,	,	PUNCT
dpc-5210	119	6	cheng	cheng	PROPN
dpc-5210	119	7	yp	yp	PROPN
dpc-5210	119	8	,	,	PUNCT
dpc-5210	119	9	hsiao	hsiao	PROPN
dpc-5210	119	10	pf	pf	PROPN
dpc-5210	119	11	,	,	PUNCT
dpc-5210	119	12	et	et	PROPN
dpc-5210	119	13	al	al	PROPN
dpc-5210	119	14	.	.	PUNCT
dpc-5210	120	1	taiwanese	taiwanese	PROPN
dpc-5210	120	2	dermatological	dermatological	ADJ
dpc-5210	120	3	association	association	NOUN
dpc-5210	120	4	consensus	consensus	NOUN
dpc-5210	120	5	recommendations	recommendation	NOUN
dpc-5210	120	6	for	for	ADP
dpc-5210	120	7	the	the	DET
dpc-5210	120	8	diagnosis	diagnosis	NOUN
dpc-5210	120	9	,	,	PUNCT
dpc-5210	120	10	assessment	assessment	NOUN
dpc-5210	120	11	,	,	PUNCT
dpc-5210	120	12	and	and	CCONJ
dpc-5210	120	13	management	management	NOUN
dpc-5210	120	14	of	of	ADP
dpc-5210	120	15	vitiligo	vitiligo	NOUN
dpc-5210	120	16	.	.	PUNCT
dpc-5210	121	1	dermatol	dermatol	NOUN
dpc-5210	121	2	sin	sin	NOUN
dpc-5210	121	3	.	.	PUNCT
dpc-5210	122	1	2025;43(1):14	2025;43(1):14	X
dpc-5210	122	2	-	-	SYM
dpc-5210	122	3	25	25	NUM
dpc-5210	122	4	.	.	PUNCT
dpc-5210	122	5	doi:10.4103	doi:10.4103	PROPN
dpc-5210	122	6	/	/	SYM
dpc-5210	122	7	ds.ds	ds.ds	PROPN
dpc-5210	122	8	-	-	PUNCT
dpc-5210	122	9	d-24	d-24	PROPN
dpc-5210	122	10	-	-	PUNCT
dpc-5210	122	11	00250	00250	NUM
dpc-5210	122	12	8	8	NUM
dpc-5210	122	13	.	.	PUNCT
dpc-5210	122	14	garza	garza	NOUN
dpc-5210	122	15	-	-	PUNCT
dpc-5210	122	16	mayers	mayers	PROPN
dpc-5210	122	17	ac	ac	PROPN
dpc-5210	122	18	,	,	PUNCT
dpc-5210	122	19	kroshinsky	kroshinsky	PROPN
dpc-5210	122	20	d.	d.	PROPN
dpc-5210	122	21	low	low	PROPN
dpc-5210	122	22	-	-	PUNCT
dpc-5210	122	23	dose	dose	NOUN
dpc-5210	122	24	methotrexate	methotrexate	NOUN
dpc-5210	122	25	for	for	ADP
dpc-5210	122	26	vitiligo	vitiligo	NOUN
dpc-5210	122	27	.	.	PUNCT
dpc-5210	123	1	j	j	PROPN
dpc-5210	123	2	drugs	drug	NOUN
dpc-5210	123	3	dermatol	dermatol	NOUN
dpc-5210	123	4	jdd	jdd	ADV
dpc-5210	123	5	.	.	PUNCT
dpc-5210	124	1	2017;16(7):705	2017;16(7):705	NUM
dpc-5210	124	2	-	-	SYM
dpc-5210	124	3	706	706	NUM
dpc-5210	124	4	.	.	PUNCT
dpc-5210	125	1	pmid	pmid	NOUN
dpc-5210	125	2	:	:	PUNCT
dpc-5210	125	3	28697225	28697225	NUM
dpc-5210	125	4	.	.	PUNCT
dpc-5210	126	1	9	9	X
dpc-5210	126	2	.	.	X
dpc-5210	126	3	alghamdi	alghamdi	PROPN
dpc-5210	126	4	k	k	PROPN
dpc-5210	126	5	,	,	PUNCT
dpc-5210	126	6	khurrum	khurrum	PROPN
dpc-5210	126	7	h.	h.	PROPN
dpc-5210	126	8	methotrexate	methotrexate	PROPN
dpc-5210	126	9	for	for	ADP
dpc-5210	126	10	the	the	DET
dpc-5210	126	11	treatment	treatment	NOUN
dpc-5210	126	12	of	of	ADP
dpc-5210	126	13	generalized	generalized	ADJ
dpc-5210	126	14	vitiligo	vitiligo	NOUN
dpc-5210	126	15	.	.	PUNCT
dpc-5210	127	1	saudi	saudi	ADJ
dpc-5210	127	2	pharm	pharm	PROPN
dpc-5210	127	3	j.	j.	PROPN
dpc-5210	127	4	2013;21(4):423	2013;21(4):423	PROPN
dpc-5210	127	5	-	-	PUNCT
dpc-5210	127	6	424	424	NUM
dpc-5210	127	7	.	.	PUNCT
dpc-5210	127	8	doi:10.1016	doi:10.1016	PROPN
dpc-5210	127	9	/	/	SYM
dpc-5210	127	10	j.jsps.2012.12.003	j.jsps.2012.12.003	PROPN
dpc-5210	127	11	.	.	PUNCT
dpc-5210	128	1	pmid	pmid	NOUN
dpc-5210	128	2	:	:	PUNCT
dpc-5210	128	3	24227963	24227963	NUM
dpc-5210	128	4	.	.	PUNCT
dpc-5210	129	1	10	10	NUM
dpc-5210	129	2	.	.	PUNCT
dpc-5210	129	3	kanwar	kanwar	PROPN
dpc-5210	129	4	aj	aj	PROPN
dpc-5210	129	5	,	,	PUNCT
dpc-5210	129	6	mahajan	mahajan	PROPN
dpc-5210	129	7	r	r	PROPN
dpc-5210	129	8	,	,	PUNCT
dpc-5210	129	9	parsad	parsad	PROPN
dpc-5210	129	10	d.	d.	PROPN
dpc-5210	129	11	low	low	PROPN
dpc-5210	129	12	-	-	PUNCT
dpc-5210	129	13	dose	dose	NOUN
dpc-5210	129	14	oral	oral	ADJ
dpc-5210	129	15	mini	mini	ADJ
dpc-5210	129	16	-	-	NOUN
dpc-5210	129	17	pulse	pulse	ADJ
dpc-5210	129	18	dexamethasone	dexamethasone	NOUN
dpc-5210	129	19	therapy	therapy	NOUN
dpc-5210	129	20	in	in	ADP
dpc-5210	129	21	progressive	progressive	ADJ
dpc-5210	129	22	unstable	unstable	ADJ
dpc-5210	129	23	vitiligo	vitiligo	NOUN
dpc-5210	129	24	.	.	PUNCT
dpc-5210	130	1	j	j	PROPN
dpc-5210	130	2	cutan	cutan	PROPN
dpc-5210	130	3	med	med	ADJ
dpc-5210	130	4	surg	surg	NOUN
dpc-5210	130	5	.	.	PUNCT
dpc-5210	131	1	2013;17(4):259	2013;17(4):259	NUM
dpc-5210	131	2	-	-	PUNCT
dpc-5210	131	3	268	268	NUM
dpc-5210	131	4	.	.	PUNCT
dpc-5210	132	1	doi:10.2310/7750.2013.12053	doi:10.2310/7750.2013.12053	NOUN
dpc-5210	132	2	.	.	PUNCT
dpc-5210	133	1	pmid	pmid	NOUN
dpc-5210	133	2	:	:	PUNCT
dpc-5210	133	3	23815959	23815959	NUM
dpc-5210	133	4	.	.	PUNCT
dpc-5210	134	1	11	11	NUM
dpc-5210	134	2	.	.	X
dpc-5210	135	1	chiu	chiu	PROPN
dpc-5210	135	2	sh	sh	PROPN
dpc-5210	135	3	,	,	PUNCT
dpc-5210	135	4	liu	liu	PROPN
dpc-5210	135	5	il	il	PROPN
dpc-5210	135	6	,	,	PUNCT
dpc-5210	135	7	chen	chen	PROPN
dpc-5210	135	8	yw	yw	PROPN
dpc-5210	135	9	,	,	PUNCT
dpc-5210	135	10	lan	lan	PROPN
dpc-5210	135	11	cce	cce	PROPN
dpc-5210	135	12	.	.	PROPN
dpc-5210	135	13	low	low	PROPN
dpc-5210	135	14	-	-	PUNCT
dpc-5210	135	15	dose	dose	NOUN
dpc-5210	135	16	uvb	uvb	ADJ
dpc-5210	135	17	therapy	therapy	NOUN
dpc-5210	135	18	is	be	AUX
dpc-5210	135	19	comparable	comparable	ADJ
dpc-5210	135	20	with	with	ADP
dpc-5210	135	21	conventional	conventional	ADJ
dpc-5210	135	22	uvb	uvb	ADJ
dpc-5210	135	23	phototherapy	phototherapy	NOUN
dpc-5210	135	24	for	for	ADP
dpc-5210	135	25	treatment	treatment	NOUN
dpc-5210	135	26	of	of	ADP
dpc-5210	135	27	vitiligo	vitiligo	NOUN
dpc-5210	135	28	:	:	PUNCT
dpc-5210	135	29	a	a	DET
dpc-5210	135	30	pilot	pilot	NOUN
dpc-5210	135	31	study	study	NOUN
dpc-5210	135	32	.	.	PUNCT
dpc-5210	136	1	j	j	PROPN
dpc-5210	136	2	dermatol	dermatol	NOUN
dpc-5210	136	3	sci	sci	PROPN
dpc-5210	136	4	.	.	PUNCT
dpc-5210	136	5	2018;92(2):218	2018;92(2):218	NUM
dpc-5210	136	6	-	-	PUNCT
dpc-5210	136	7	220	220	NUM
dpc-5210	136	8	.	.	PUNCT
dpc-5210	136	9	doi:10.1016	doi:10.1016	PROPN
dpc-5210	136	10	/	/	SYM
dpc-5210	136	11	j.jdermsci.2018.08.006	j.jdermsci.2018.08.006	PROPN
dpc-5210	136	12	.	.	PUNCT
dpc-5210	137	1	pmid	pmid	NOUN
dpc-5210	137	2	:	:	PUNCT
dpc-5210	137	3	30227989	30227989	NUM
dpc-5210	137	4	.	.	PUNCT
dpc-5210	138	1	12	12	NUM
dpc-5210	138	2	.	.	PUNCT
dpc-5210	139	1	singh	singh	PROPN
dpc-5210	139	2	a	a	PROPN
dpc-5210	139	3	,	,	PUNCT
dpc-5210	139	4	kanwar	kanwar	PROPN
dpc-5210	139	5	a	a	PRON
dpc-5210	139	6	,	,	PUNCT
dpc-5210	139	7	parsad	parsad	PROPN
dpc-5210	139	8	d	d	PROPN
dpc-5210	139	9	,	,	PUNCT
dpc-5210	139	10	mahajan	mahajan	PROPN
dpc-5210	139	11	r.	r.	PROPN
dpc-5210	139	12	randomized	randomize	VERB
dpc-5210	139	13	controlled	control	VERB
dpc-5210	139	14	study	study	NOUN
dpc-5210	139	15	to	to	PART
dpc-5210	139	16	evaluate	evaluate	VERB
dpc-5210	139	17	the	the	DET
dpc-5210	139	18	effectiveness	effectiveness	NOUN
dpc-5210	139	19	of	of	ADP
dpc-5210	139	20	dexamethasone	dexamethasone	NOUN
dpc-5210	139	21	oral	oral	ADJ
dpc-5210	139	22	minipulse	minipulse	NOUN
dpc-5210	139	23	therapy	therapy	NOUN
dpc-5210	139	24	versus	versus	ADP
dpc-5210	139	25	oral	oral	ADJ
dpc-5210	139	26	minocycline	minocycline	NOUN
dpc-5210	139	27	in	in	ADP
dpc-5210	139	28	patients	patient	NOUN
dpc-5210	139	29	with	with	ADP
dpc-5210	139	30	active	active	ADJ
dpc-5210	139	31	vitiligo	vitiligo	NOUN
dpc-5210	139	32	vulgaris	vulgaris	NOUN
dpc-5210	139	33	.	.	PUNCT
dpc-5210	140	1	indian	indian	PROPN
dpc-5210	140	2	j	j	PROPN
dpc-5210	140	3	dermatol	dermatol	PROPN
dpc-5210	140	4	venereol	venereol	NOUN
dpc-5210	140	5	leprol.2014;80(1):29.doi:10.4103/0378	leprol.2014;80(1):29.doi:10.4103/0378	PROPN
dpc-5210	140	6	-	-	PUNCT
dpc-5210	140	7	6323.125479	6323.125479	NOUN
dpc-5210	140	8	.	.	PUNCT
dpc-5210	141	1	pmid	pmid	NOUN
dpc-5210	141	2	:	:	PUNCT
dpc-5210	141	3	24448120	24448120	NUM
dpc-5210	141	4	.	.	PUNCT
dpc-5210	142	1	involvement	involvement	NOUN
dpc-5210	142	2	were	be	AUX
dpc-5210	142	3	less	less	ADV
dpc-5210	142	4	likely	likely	ADJ
dpc-5210	142	5	to	to	PART
dpc-5210	142	6	require	require	VERB
dpc-5210	142	7	continuous	continuous	ADJ
dpc-5210	142	8	systemic	systemic	ADJ
dpc-5210	142	9	treatment	treatment	NOUN
dpc-5210	142	10	for	for	ADP
dpc-5210	142	11	more	more	ADJ
dpc-5210	142	12	than	than	ADP
dpc-5210	142	13	16	16	NUM
dpc-5210	142	14	weeks	week	NOUN
dpc-5210	142	15	to	to	PART
dpc-5210	142	16	achieve	achieve	VERB
dpc-5210	142	17	disease	disease	NOUN
dpc-5210	142	18	stabilization	stabilization	NOUN
dpc-5210	142	19	.	.	PUNCT
dpc-5210	143	1	however	however	ADV
dpc-5210	143	2	,	,	PUNCT
dpc-5210	143	3	within	within	ADP
dpc-5210	143	4	six	six	NUM
dpc-5210	143	5	months	month	NOUN
dpc-5210	143	6	from	from	ADP
dpc-5210	143	7	treatment	treatment	NOUN
dpc-5210	143	8	initiation	initiation	NOUN
dpc-5210	143	9	,	,	PUNCT
dpc-5210	143	10	more	more	ADJ
dpc-5210	143	11	than	than	ADP
dpc-5210	143	12	one	one	NUM
dpc-5210	143	13	-	-	PUNCT
dpc-5210	143	14	third	third	NOUN
dpc-5210	143	15	of	of	ADP
dpc-5210	143	16	active	active	ADJ
dpc-5210	143	17	vitiligo	vitiligo	NOUN
dpc-5210	143	18	patients	patient	NOUN
dpc-5210	143	19	required	require	VERB
dpc-5210	143	20	prolonged	prolonged	ADJ
dpc-5210	143	21	systemic	systemic	ADJ
dpc-5210	143	22	treatment	treatment	NOUN
dpc-5210	143	23	or	or	CCONJ
dpc-5210	143	24	multiple	multiple	ADJ
dpc-5210	143	25	courses	course	NOUN
dpc-5210	143	26	of	of	ADP
dpc-5210	143	27	systemic	systemic	ADJ
dpc-5210	143	28	treatments	treatment	NOUN
dpc-5210	143	29	to	to	PART
dpc-5210	143	30	stabilize	stabilize	VERB
dpc-5210	143	31	their	their	PRON
dpc-5210	143	32	disease	disease	NOUN
dpc-5210	143	33	.	.	PUNCT
dpc-5210	144	1	in	in	ADP
dpc-5210	144	2	many	many	ADJ
dpc-5210	144	3	clinical	clinical	ADJ
dpc-5210	144	4	studies	study	NOUN
dpc-5210	144	5	,	,	PUNCT
dpc-5210	144	6	the	the	DET
dpc-5210	144	7	efficacy	efficacy	NOUN
dpc-5210	144	8	of	of	ADP
dpc-5210	144	9	systemic	systemic	ADJ
dpc-5210	144	10	treatment	treatment	NOUN
dpc-5210	144	11	is	be	AUX
dpc-5210	144	12	evaluated	evaluate	VERB
dpc-5210	144	13	at	at	ADP
dpc-5210	144	14	the	the	DET
dpc-5210	144	15	sixth	sixth	ADJ
dpc-5210	144	16	month	month	NOUN
dpc-5210	144	17	of	of	ADP
dpc-5210	144	18	treatment	treatment	NOUN
dpc-5210	144	19	,	,	PUNCT
dpc-5210	144	20	and	and	CCONJ
dpc-5210	144	21	information	information	NOUN
dpc-5210	144	22	regarding	regard	VERB
dpc-5210	144	23	the	the	DET
dpc-5210	144	24	clinical	clinical	ADJ
dpc-5210	144	25	course	course	NOUN
dpc-5210	144	26	of	of	ADP
dpc-5210	144	27	vitiligo	vitiligo	NOUN
dpc-5210	144	28	beyond	beyond	ADP
dpc-5210	144	29	the	the	DET
dpc-5210	144	30	follow	follow	NOUN
dpc-5210	144	31	-	-	PUNCT
dpc-5210	144	32	up	up	NOUN
dpc-5210	144	33	period	period	NOUN
dpc-5210	144	34	is	be	AUX
dpc-5210	144	35	lacking	lack	VERB
dpc-5210	144	36	[	[	X
dpc-5210	144	37	5,6,12	5,6,12	NUM
dpc-5210	144	38	]	]	PUNCT
dpc-5210	144	39	.	.	PUNCT
dpc-5210	145	1	in	in	ADP
dpc-5210	145	2	this	this	DET
dpc-5210	145	3	study	study	NOUN
dpc-5210	145	4	,	,	PUNCT
dpc-5210	145	5	we	we	PRON
dpc-5210	145	6	further	far	ADV
dpc-5210	145	7	examined	examine	VERB
dpc-5210	145	8	the	the	DET
dpc-5210	145	9	number	number	NOUN
dpc-5210	145	10	of	of	ADP
dpc-5210	145	11	patients	patient	NOUN
dpc-5210	145	12	requiring	require	VERB
dpc-5210	145	13	subsequent	subsequent	ADJ
dpc-5210	145	14	systemic	systemic	ADJ
dpc-5210	145	15	treatment	treatment	NOUN
dpc-5210	145	16	due	due	ADP
dpc-5210	145	17	to	to	ADP
dpc-5210	145	18	disease	disease	NOUN
dpc-5210	145	19	reactivation	reactivation	NOUN
dpc-5210	145	20	one	one	NUM
dpc-5210	145	21	year	year	NOUN
dpc-5210	145	22	after	after	SCONJ
dpc-5210	145	23	stabilization	stabilization	NOUN
dpc-5210	145	24	had	have	AUX
dpc-5210	145	25	been	be	AUX
dpc-5210	145	26	achieved	achieve	VERB
dpc-5210	145	27	by	by	ADP
dpc-5210	145	28	systemic	systemic	ADJ
dpc-5210	145	29	treatment	treatment	NOUN
dpc-5210	145	30	.	.	PUNCT
dpc-5210	146	1	although	although	SCONJ
dpc-5210	146	2	12	12	NUM
dpc-5210	146	3	to	to	PART
dpc-5210	146	4	16	16	NUM
dpc-5210	146	5	weeks	week	NOUN
dpc-5210	146	6	of	of	ADP
dpc-5210	146	7	systemic	systemic	ADJ
dpc-5210	146	8	immunosuppressant	immunosuppressant	NOUN
dpc-5210	146	9	is	be	AUX
dpc-5210	146	10	adequate	adequate	ADJ
dpc-5210	146	11	to	to	PART
dpc-5210	146	12	induce	induce	VERB
dpc-5210	146	13	stabilization	stabilization	NOUN
dpc-5210	146	14	for	for	ADP
dpc-5210	146	15	approximately	approximately	ADV
dpc-5210	146	16	60	60	NUM
dpc-5210	146	17	%	%	NOUN
dpc-5210	146	18	of	of	ADP
dpc-5210	146	19	vitiligo	vitiligo	ADJ
dpc-5210	146	20	patients	patient	NOUN
dpc-5210	146	21	with	with	ADP
dpc-5210	146	22	active	active	ADJ
dpc-5210	146	23	disease	disease	NOUN
dpc-5210	146	24	,	,	PUNCT
dpc-5210	146	25	flare	flare	NOUN
dpc-5210	146	26	-	-	PUNCT
dpc-5210	146	27	up	up	NOUN
dpc-5210	146	28	of	of	ADP
dpc-5210	146	29	disease	disease	NOUN
dpc-5210	146	30	activity	activity	NOUN
dpc-5210	146	31	may	may	AUX
dpc-5210	146	32	occur	occur	VERB
dpc-5210	146	33	in	in	ADP
dpc-5210	146	34	more	more	ADJ
dpc-5210	146	35	than	than	ADP
dpc-5210	146	36	10	10	NUM
dpc-5210	146	37	%	%	NOUN
dpc-5210	146	38	of	of	ADP
dpc-5210	146	39	patients	patient	NOUN
dpc-5210	146	40	who	who	PRON
dpc-5210	146	41	showed	show	VERB
dpc-5210	146	42	initial	initial	ADJ
dpc-5210	146	43	stabilization	stabilization	NOUN
dpc-5210	146	44	at	at	ADP
dpc-5210	146	45	1	1	NUM
dpc-5210	146	46	-	-	PUNCT
dpc-5210	146	47	year	year	NOUN
dpc-5210	146	48	follow	follow	NOUN
dpc-5210	146	49	-	-	PUNCT
dpc-5210	146	50	up	up	NOUN
dpc-5210	146	51	from	from	ADP
dpc-5210	146	52	treatment	treatment	NOUN
dpc-5210	146	53	initiation	initiation	NOUN
dpc-5210	146	54	.	.	PUNCT
dpc-5210	147	1	in	in	ADP
dpc-5210	147	2	previous	previous	ADJ
dpc-5210	147	3	studies	study	NOUN
dpc-5210	147	4	,	,	PUNCT
dpc-5210	147	5	the	the	DET
dpc-5210	147	6	1	1	NUM
dpc-5210	147	7	-	-	PUNCT
dpc-5210	147	8	year	year	NOUN
dpc-5210	147	9	recurrence	recurrence	NOUN
dpc-5210	147	10	rate	rate	NOUN
dpc-5210	147	11	of	of	ADP
dpc-5210	147	12	non	non	ADJ
dpc-5210	147	13	-	-	ADJ
dpc-5210	147	14	segmental	segmental	ADJ
dpc-5210	147	15	vitiligo	vitiligo	NOUN
dpc-5210	147	16	treated	treat	VERB
dpc-5210	147	17	with	with	ADP
dpc-5210	147	18	topical	topical	ADJ
dpc-5210	147	19	tacrolimus	tacrolimus	NOUN
dpc-5210	147	20	0.1	0.1	NUM
dpc-5210	147	21	%	%	NOUN
dpc-5210	147	22	and	and	CCONJ
dpc-5210	147	23	narrowband	narrowband	NOUN
dpc-5210	147	24	uvb	uvb	NOUN
dpc-5210	147	25	were	be	AUX
dpc-5210	147	26	reported	report	VERB
dpc-5210	147	27	to	to	PART
dpc-5210	147	28	be	be	AUX
dpc-5210	147	29	40	40	NUM
dpc-5210	147	30	%	%	NOUN
dpc-5210	147	31	and	and	CCONJ
dpc-5210	147	32	44	44	NUM
dpc-5210	147	33	%	%	NOUN
dpc-5210	147	34	,	,	PUNCT
dpc-5210	147	35	respectively	respectively	ADV
dpc-5210	147	36	[	[	X
dpc-5210	147	37	13,14	13,14	NUM
dpc-5210	147	38	]	]	PUNCT
dpc-5210	147	39	.	.	PUNCT
dpc-5210	148	1	recently	recently	ADV
dpc-5210	148	2	,	,	PUNCT
dpc-5210	148	3	xu	xu	PROPN
dpc-5210	148	4	et	et	PROPN
dpc-5210	148	5	al	al	PROPN
dpc-5210	148	6	.	.	PROPN
dpc-5210	148	7	reported	report	VERB
dpc-5210	148	8	recurrence	recurrence	NOUN
dpc-5210	148	9	rates	rate	NOUN
dpc-5210	148	10	of	of	ADP
dpc-5210	148	11	23.7	23.7	NUM
dpc-5210	148	12	%	%	NOUN
dpc-5210	148	13	and	and	CCONJ
dpc-5210	148	14	26.3	26.3	NUM
dpc-5210	148	15	%	%	NOUN
dpc-5210	148	16	at	at	ADP
dpc-5210	148	17	6	6	NUM
dpc-5210	148	18	-	-	PUNCT
dpc-5210	148	19	month	month	NOUN
dpc-5210	148	20	and	and	CCONJ
dpc-5210	148	21	1	1	NUM
dpc-5210	148	22	-	-	PUNCT
dpc-5210	148	23	year	year	NOUN
dpc-5210	148	24	follow	follow	NOUN
dpc-5210	148	25	-	-	PUNCT
dpc-5210	148	26	up	up	NOUN
dpc-5210	148	27	in	in	ADP
dpc-5210	148	28	vitiligo	vitiligo	ADJ
dpc-5210	148	29	patients	patient	NOUN
dpc-5210	148	30	with	with	ADP
dpc-5210	148	31	>	>	SYM
dpc-5210	148	32	80	80	NUM
dpc-5210	148	33	%	%	NOUN
dpc-5210	148	34	repigmentation	repigmentation	NOUN
dpc-5210	148	35	receiving	receive	VERB
dpc-5210	148	36	treatment	treatment	NOUN
dpc-5210	148	37	with	with	ADP
dpc-5210	148	38	traditional	traditional	ADJ
dpc-5210	148	39	chinese	chinese	ADJ
dpc-5210	148	40	medicine	medicine	NOUN
dpc-5210	148	41	[	[	X
dpc-5210	148	42	15	15	NUM
dpc-5210	148	43	]	]	PUNCT
dpc-5210	148	44	.	.	PUNCT
dpc-5210	149	1	the	the	DET
dpc-5210	149	2	lower	low	ADJ
dpc-5210	149	3	reactivation	reactivation	NOUN
dpc-5210	149	4	rate	rate	NOUN
dpc-5210	149	5	in	in	ADP
dpc-5210	149	6	the	the	DET
dpc-5210	149	7	present	present	ADJ
dpc-5210	149	8	study	study	NOUN
dpc-5210	149	9	may	may	AUX
dpc-5210	149	10	be	be	AUX
dpc-5210	149	11	due	due	ADJ
dpc-5210	149	12	to	to	ADP
dpc-5210	149	13	the	the	DET
dpc-5210	149	14	difference	difference	NOUN
dpc-5210	149	15	in	in	ADP
dpc-5210	149	16	treatment	treatment	NOUN
dpc-5210	149	17	modalities	modality	NOUN
dpc-5210	149	18	.	.	PUNCT
dpc-5210	150	1	this	this	DET
dpc-5210	150	2	study	study	NOUN
dpc-5210	150	3	has	have	VERB
dpc-5210	150	4	several	several	ADJ
dpc-5210	150	5	limitations	limitation	NOUN
dpc-5210	150	6	.	.	PUNCT
dpc-5210	151	1	first	first	ADV
dpc-5210	151	2	,	,	PUNCT
dpc-5210	151	3	the	the	DET
dpc-5210	151	4	retrospective	retrospective	ADJ
dpc-5210	151	5	nature	nature	NOUN
dpc-5210	151	6	of	of	ADP
dpc-5210	151	7	this	this	DET
dpc-5210	151	8	study	study	NOUN
dpc-5210	151	9	may	may	AUX
dpc-5210	151	10	have	have	AUX
dpc-5210	151	11	resulted	result	VERB
dpc-5210	151	12	in	in	ADP
dpc-5210	151	13	potential	potential	ADJ
dpc-5210	151	14	biases	bias	NOUN
dpc-5210	151	15	in	in	ADP
dpc-5210	151	16	data	datum	NOUN
dpc-5210	151	17	collection	collection	NOUN
dpc-5210	151	18	.	.	PUNCT
dpc-5210	152	1	second	second	ADJ
dpc-5210	152	2	,	,	PUNCT
dpc-5210	152	3	the	the	DET
dpc-5210	152	4	number	number	NOUN
dpc-5210	152	5	of	of	ADP
dpc-5210	152	6	patients	patient	NOUN
dpc-5210	152	7	included	include	VERB
dpc-5210	152	8	in	in	ADP
dpc-5210	152	9	group	group	NOUN
dpc-5210	152	10	3	3	NUM
dpc-5210	152	11	is	be	AUX
dpc-5210	152	12	relatively	relatively	ADV
dpc-5210	152	13	small	small	ADJ
dpc-5210	152	14	compared	compare	VERB
dpc-5210	152	15	with	with	ADP
dpc-5210	152	16	the	the	DET
dpc-5210	152	17	other	other	ADJ
dpc-5210	152	18	groups	group	NOUN
dpc-5210	152	19	,	,	PUNCT
dpc-5210	152	20	which	which	PRON
dpc-5210	152	21	may	may	AUX
dpc-5210	152	22	potentially	potentially	ADV
dpc-5210	152	23	have	have	AUX
dpc-5210	152	24	reduced	reduce	VERB
dpc-5210	152	25	statistical	statistical	ADJ
dpc-5210	152	26	power	power	NOUN
dpc-5210	152	27	.	.	PUNCT
dpc-5210	153	1	thirdly	thirdly	ADV
dpc-5210	153	2	,	,	PUNCT
dpc-5210	153	3	the	the	DET
dpc-5210	153	4	progression	progression	NOUN
dpc-5210	153	5	of	of	ADP
dpc-5210	153	6	vitiligo	vitiligo	ADJ
dpc-5210	153	7	lesions	lesion	NOUN
dpc-5210	153	8	was	be	AUX
dpc-5210	153	9	not	not	PART
dpc-5210	153	10	evaluated	evaluate	VERB
dpc-5210	153	11	using	use	VERB
dpc-5210	153	12	standardized	standardized	ADJ
dpc-5210	153	13	severity	severity	NOUN
dpc-5210	153	14	assessment	assessment	NOUN
dpc-5210	153	15	tools	tool	NOUN
dpc-5210	153	16	such	such	ADJ
dpc-5210	153	17	as	as	ADP
dpc-5210	153	18	vitiligo	vitiligo	NOUN
dpc-5210	153	19	area	area	NOUN
dpc-5210	153	20	scoring	scoring	NOUN
dpc-5210	153	21	index	index	NOUN
dpc-5210	153	22	(	(	PUNCT
dpc-5210	153	23	vasi	vasi	PROPN
dpc-5210	153	24	)	)	PUNCT
dpc-5210	153	25	or	or	CCONJ
dpc-5210	153	26	vitiligo	vitiligo	NOUN
dpc-5210	153	27	extent	extent	NOUN
dpc-5210	153	28	score	score	NOUN
dpc-5210	153	29	(	(	PUNCT
dpc-5210	153	30	ves	f	NOUN
dpc-5210	153	31	)	)	PUNCT
dpc-5210	153	32	but	but	CCONJ
dpc-5210	153	33	based	base	VERB
dpc-5210	153	34	on	on	ADP
dpc-5210	153	35	clinical	clinical	ADJ
dpc-5210	153	36	documentation	documentation	NOUN
dpc-5210	153	37	and	and	CCONJ
dpc-5210	153	38	photos	photo	NOUN
dpc-5210	153	39	during	during	ADP
dpc-5210	153	40	each	each	DET
dpc-5210	153	41	visit	visit	NOUN
dpc-5210	153	42	,	,	PUNCT
dpc-5210	153	43	which	which	PRON
dpc-5210	153	44	may	may	AUX
dpc-5210	153	45	have	have	AUX
dpc-5210	153	46	produced	produce	VERB
dpc-5210	153	47	less	less	ADJ
dpc-5210	153	48	objective	objective	ADJ
dpc-5210	153	49	results	result	NOUN
dpc-5210	153	50	.	.	PUNCT
dpc-5210	154	1	lastly	lastly	ADV
dpc-5210	154	2	,	,	PUNCT
dpc-5210	154	3	patients	patient	NOUN
dpc-5210	154	4	were	be	AUX
dpc-5210	154	5	not	not	PART
dpc-5210	154	6	stratified	stratify	VERB
dpc-5210	154	7	by	by	ADP
dpc-5210	154	8	treatment	treatment	NOUN
dpc-5210	154	9	(	(	PUNCT
dpc-5210	154	10	oral	oral	ADJ
dpc-5210	154	11	mini	mini	ADJ
dpc-5210	154	12	-	-	NOUN
dpc-5210	154	13	pulse	pulse	ADJ
dpc-5210	154	14	corticosteroid	corticosteroid	NOUN
dpc-5210	154	15	or	or	CCONJ
dpc-5210	154	16	methotrexate	methotrexate	NOUN
dpc-5210	154	17	)	)	PUNCT
dpc-5210	154	18	,	,	PUNCT
dpc-5210	154	19	which	which	PRON
dpc-5210	154	20	may	may	AUX
dpc-5210	154	21	have	have	AUX
dpc-5210	154	22	influenced	influence	VERB
dpc-5210	154	23	treatment	treatment	NOUN
dpc-5210	154	24	outcomes	outcome	NOUN
dpc-5210	154	25	.	.	PUNCT
dpc-5210	155	1	however	however	ADV
dpc-5210	155	2	,	,	PUNCT
dpc-5210	155	3	both	both	DET
dpc-5210	155	4	treatments	treatment	NOUN
dpc-5210	155	5	are	be	AUX
dpc-5210	155	6	recommended	recommend	VERB
dpc-5210	155	7	by	by	ADP
dpc-5210	155	8	several	several	ADJ
dpc-5210	155	9	guidelines	guideline	NOUN
dpc-5210	155	10	and	and	CCONJ
dpc-5210	155	11	are	be	AUX
dpc-5210	155	12	equally	equally	ADV
dpc-5210	155	13	effective	effective	ADJ
dpc-5210	155	14	in	in	ADP
dpc-5210	155	15	suppressing	suppress	VERB
dpc-5210	155	16	the	the	DET
dpc-5210	155	17	activity	activity	NOUN
dpc-5210	155	18	of	of	ADP
dpc-5210	155	19	active	active	ADJ
dpc-5210	155	20	vitiligo	vitiligo	NOUN
dpc-5210	156	1	[	[	X
dpc-5210	156	2	5	5	NUM
dpc-5210	156	3	]	]	PUNCT
dpc-5210	156	4	.	.	PUNCT
dpc-5210	157	1	in	in	ADP
dpc-5210	157	2	the	the	DET
dpc-5210	157	3	present	present	ADJ
dpc-5210	157	4	study	study	NOUN
dpc-5210	157	5	,	,	PUNCT
dpc-5210	157	6	treatment	treatment	NOUN
dpc-5210	157	7	choice	choice	NOUN
dpc-5210	157	8	was	be	AUX
dpc-5210	157	9	determined	determine	VERB
dpc-5210	157	10	through	through	ADP
dpc-5210	157	11	shared	share	VERB
dpc-5210	157	12	-	-	PUNCT
dpc-5210	157	13	decision	decision	NOUN
dpc-5210	157	14	making	making	NOUN
dpc-5210	157	15	with	with	ADP
dpc-5210	157	16	the	the	DET
dpc-5210	157	17	patient	patient	NOUN
dpc-5210	157	18	.	.	PUNCT
dpc-5210	158	1	of	of	ADP
dpc-5210	158	2	the	the	DET
dpc-5210	158	3	42	42	NUM
dpc-5210	158	4	patients	patient	NOUN
dpc-5210	158	5	who	who	PRON
dpc-5210	158	6	received	receive	VERB
dpc-5210	158	7	methotrexate	methotrexate	NOUN
dpc-5210	158	8	treatment	treatment	NOUN
dpc-5210	158	9	,	,	PUNCT
dpc-5210	158	10	only	only	ADV
dpc-5210	158	11	one	one	NUM
dpc-5210	158	12	patient	patient	NOUN
dpc-5210	158	13	did	do	AUX
dpc-5210	158	14	not	not	PART
dpc-5210	158	15	receive	receive	VERB
dpc-5210	158	16	any	any	DET
dpc-5210	158	17	oral	oral	ADJ
dpc-5210	158	18	mini	mini	ADJ
dpc-5210	158	19	-	-	ADJ
dpc-5210	158	20	pulse	pulse	ADJ
dpc-5210	158	21	corticosteroid	corticosteroid	ADJ
dpc-5210	158	22	therapy	therapy	NOUN
dpc-5210	158	23	,	,	PUNCT
dpc-5210	158	24	and	and	CCONJ
dpc-5210	158	25	38	38	NUM
dpc-5210	158	26	patients	patient	NOUN
dpc-5210	158	27	received	receive	VERB
dpc-5210	158	28	mini	mini	ADJ
dpc-5210	158	29	-	-	ADJ
dpc-5210	158	30	pulse	pulse	ADJ
dpc-5210	158	31	corticosteroid	corticosteroid	NOUN
dpc-5210	158	32	therapy	therapy	NOUN
dpc-5210	158	33	prior	prior	ADV
dpc-5210	158	34	to	to	ADP
dpc-5210	158	35	methotrexate	methotrexate	NOUN
dpc-5210	158	36	,	,	PUNCT
dpc-5210	158	37	making	make	VERB
dpc-5210	158	38	it	it	PRON
dpc-5210	158	39	difficult	difficult	ADJ
dpc-5210	158	40	to	to	PART
dpc-5210	158	41	isolate	isolate	VERB
dpc-5210	158	42	the	the	DET
dpc-5210	158	43	effect	effect	NOUN
dpc-5210	158	44	of	of	ADP
dpc-5210	158	45	each	each	DET
dpc-5210	158	46	medication	medication	NOUN
dpc-5210	158	47	.	.	PUNCT
dpc-5210	159	1	currently	currently	ADV
dpc-5210	159	2	,	,	PUNCT
dpc-5210	159	3	it	it	PRON
dpc-5210	159	4	is	be	AUX
dpc-5210	159	5	difficult	difficult	ADJ
dpc-5210	159	6	to	to	PART
dpc-5210	159	7	predict	predict	VERB
dpc-5210	159	8	which	which	DET
dpc-5210	159	9	specific	specific	ADJ
dpc-5210	159	10	patient	patient	NOUN
dpc-5210	159	11	will	will	AUX
dpc-5210	159	12	require	require	VERB
dpc-5210	159	13	extended	extended	ADJ
dpc-5210	159	14	treatment	treatment	NOUN
dpc-5210	159	15	.	.	PUNCT
dpc-5210	160	1	given	give	VERB
dpc-5210	160	2	that	that	SCONJ
dpc-5210	160	3	vitiligo	vitiligo	NOUN
dpc-5210	160	4	patients	patient	NOUN
dpc-5210	160	5	often	often	ADV
dpc-5210	160	6	require	require	VERB
dpc-5210	160	7	a	a	DET
dpc-5210	160	8	long	long	ADJ
dpc-5210	160	9	treatment	treatment	NOUN
dpc-5210	160	10	course	course	NOUN
dpc-5210	160	11	to	to	PART
dpc-5210	160	12	obtain	obtain	VERB
dpc-5210	160	13	satisfactory	satisfactory	ADJ
dpc-5210	160	14	repigmentation	repigmentation	NOUN
dpc-5210	160	15	[	[	X
dpc-5210	160	16	1	1	NUM
dpc-5210	160	17	]	]	PUNCT
dpc-5210	160	18	,	,	PUNCT
dpc-5210	160	19	and	and	CCONJ
dpc-5210	160	20	unsynchronized	unsynchronized	ADJ
dpc-5210	160	21	original	original	ADJ
dpc-5210	160	22	article	article	NOUN
dpc-5210	160	23	|	|	ADV
dpc-5210	160	24	dermatol	dermatol	ADJ
dpc-5210	160	25	pract	pract	NOUN
dpc-5210	160	26	concept	concept	NOUN
dpc-5210	160	27	.	.	PUNCT
dpc-5210	161	1	2025;15(4):5210	2025;15(4):5210	PROPN
dpc-5210	161	2	5	5	NUM
dpc-5210	161	3	15	15	NUM
dpc-5210	161	4	.	.	PUNCT
dpc-5210	162	1	xu	xu	PROPN
dpc-5210	163	1	w	w	PROPN
dpc-5210	163	2	,	,	PUNCT
dpc-5210	163	3	qiu	qiu	PROPN
dpc-5210	163	4	z	z	PROPN
dpc-5210	163	5	,	,	PUNCT
dpc-5210	163	6	li	li	PROPN
dpc-5210	163	7	c	c	PROPN
dpc-5210	163	8	,	,	PUNCT
dpc-5210	163	9	et	et	PROPN
dpc-5210	163	10	al	al	PROPN
dpc-5210	163	11	.	.	PROPN
dpc-5210	163	12	recurrence	recurrence	NOUN
dpc-5210	163	13	and	and	CCONJ
dpc-5210	163	14	risk	risk	NOUN
dpc-5210	163	15	factors	factor	NOUN
dpc-5210	163	16	in	in	ADP
dpc-5210	163	17	cured	cure	VERB
dpc-5210	163	18	patients	patient	NOUN
dpc-5210	163	19	with	with	ADP
dpc-5210	163	20	vitiligo	vitiligo	NOUN
dpc-5210	163	21	:	:	PUNCT
dpc-5210	163	22	a	a	DET
dpc-5210	163	23	real	real	ADJ
dpc-5210	163	24	-	-	PUNCT
dpc-5210	163	25	life	life	NOUN
dpc-5210	163	26	single	single	ADJ
dpc-5210	163	27	-	-	PUNCT
dpc-5210	163	28	center	center	NOUN
dpc-5210	163	29	retrospective	retrospective	ADJ
dpc-5210	163	30	study	study	NOUN
dpc-5210	163	31	.	.	PUNCT
dpc-5210	164	1	j	j	PROPN
dpc-5210	164	2	cosmet	cosmet	PROPN
dpc-5210	164	3	dermatol	dermatol	NOUN
dpc-5210	164	4	.	.	PUNCT
dpc-5210	165	1	2023;22(5):1680	2023;22(5):1680	NUM
dpc-5210	165	2	-	-	SYM
dpc-5210	165	3	1684.doi:10.1111	1684.doi:10.1111	NUM
dpc-5210	165	4	/jocd.15637	/jocd.15637	PUNCT
dpc-5210	165	5	.	.	PUNCT
dpc-5210	166	1	pmid	pmid	NOUN
dpc-5210	166	2	:	:	PUNCT
dpc-5210	166	3	36721299	36721299	NUM
dpc-5210	166	4	.	.	PUNCT
dpc-5210	167	1	16	16	NUM
dpc-5210	167	2	.	.	PUNCT
dpc-5210	168	1	parsad	parsad	PROPN
dpc-5210	168	2	d	d	PROPN
dpc-5210	168	3	,	,	PUNCT
dpc-5210	168	4	pandhi	pandhi	NOUN
dpc-5210	168	5	r	r	NOUN
dpc-5210	168	6	,	,	PUNCT
dpc-5210	168	7	dogra	dogra	PROPN
dpc-5210	168	8	s	s	PROPN
dpc-5210	168	9	,	,	PUNCT
dpc-5210	168	10	kumar	kumar	PROPN
dpc-5210	168	11	b.	b.	PROPN
dpc-5210	168	12	clinical	clinical	PROPN
dpc-5210	168	13	study	study	NOUN
dpc-5210	168	14	of	of	ADP
dpc-5210	168	15	repigmentation	repigmentation	NOUN
dpc-5210	168	16	patterns	pattern	NOUN
dpc-5210	168	17	with	with	ADP
dpc-5210	168	18	different	different	ADJ
dpc-5210	168	19	treatment	treatment	NOUN
dpc-5210	168	20	modalities	modality	NOUN
dpc-5210	168	21	and	and	CCONJ
dpc-5210	168	22	their	their	PRON
dpc-5210	168	23	correlation	correlation	NOUN
dpc-5210	168	24	with	with	ADP
dpc-5210	168	25	speed	speed	NOUN
dpc-5210	168	26	and	and	CCONJ
dpc-5210	168	27	stability	stability	NOUN
dpc-5210	168	28	of	of	ADP
dpc-5210	168	29	repigmentation	repigmentation	NOUN
dpc-5210	168	30	in	in	ADP
dpc-5210	168	31	352	352	NUM
dpc-5210	168	32	vitiliginous	vitiliginous	ADJ
dpc-5210	168	33	patches	patch	NOUN
dpc-5210	168	34	.	.	PUNCT
dpc-5210	169	1	j	j	PROPN
dpc-5210	169	2	am	be	AUX
dpc-5210	169	3	acad	acad	ADJ
dpc-5210	169	4	dermatol	dermatol	NOUN
dpc-5210	169	5	.	.	PUNCT
dpc-5210	170	1	2004;50(1	2004;50(1	NUM
dpc-5210	170	2	):	):	PUNCT
dpc-5210	170	3	63	63	NUM
dpc-5210	170	4	-	-	SYM
dpc-5210	170	5	67.doi:10.1016	67.doi:10.1016	NUM
dpc-5210	170	6	/	/	SYM
dpc-5210	170	7	s0190	s0190	VERB
dpc-5210	170	8	-	-	PUNCT
dpc-5210	170	9	9622(03)00786	9622(03)00786	NUM
dpc-5210	170	10	-	-	PUNCT
dpc-5210	170	11	2.pmid	2.pmid	NUM
dpc-5210	170	12	:	:	PUNCT
dpc-5210	170	13	14699367	14699367	NUM
dpc-5210	170	14	.	.	PUNCT
dpc-5210	171	1	13	13	NUM
dpc-5210	171	2	.	.	PUNCT
dpc-5210	172	1	nicolaidou	nicolaidou	PROPN
dpc-5210	172	2	e	e	PROPN
dpc-5210	172	3	,	,	PUNCT
dpc-5210	172	4	antoniou	antoniou	PROPN
dpc-5210	172	5	c	c	PROPN
dpc-5210	172	6	,	,	PUNCT
dpc-5210	172	7	stratigos	stratigos	PROPN
dpc-5210	172	8	aj	aj	PROPN
dpc-5210	172	9	,	,	PUNCT
dpc-5210	172	10	stefanaki	stefanaki	PROPN
dpc-5210	172	11	c	c	PROPN
dpc-5210	172	12	,	,	PUNCT
dpc-5210	172	13	katsambas	katsambas	PROPN
dpc-5210	172	14	ad	ad	NOUN
dpc-5210	172	15	.	.	PUNCT
dpc-5210	173	1	efficacy	efficacy	NOUN
dpc-5210	173	2	,	,	PUNCT
dpc-5210	173	3	predictors	predictor	NOUN
dpc-5210	173	4	of	of	ADP
dpc-5210	173	5	response	response	NOUN
dpc-5210	173	6	,	,	PUNCT
dpc-5210	173	7	and	and	CCONJ
dpc-5210	173	8	long	long	ADJ
dpc-5210	173	9	-	-	PUNCT
dpc-5210	173	10	term	term	NOUN
dpc-5210	173	11	follow	follow	NOUN
dpc-5210	173	12	-	-	PUNCT
dpc-5210	173	13	up	up	NOUN
dpc-5210	173	14	in	in	ADP
dpc-5210	173	15	patients	patient	NOUN
dpc-5210	173	16	with	with	ADP
dpc-5210	173	17	vitiligo	vitiligo	PROPN
dpc-5210	173	18	treated	treat	VERB
dpc-5210	173	19	with	with	ADP
dpc-5210	173	20	narrowband	narrowband	NOUN
dpc-5210	173	21	uvb	uvb	ADJ
dpc-5210	173	22	phototherapy	phototherapy	NOUN
dpc-5210	173	23	.	.	PUNCT
dpc-5210	174	1	j	j	PROPN
dpc-5210	174	2	am	be	AUX
dpc-5210	174	3	acad	acad	ADJ
dpc-5210	174	4	dermatol	dermatol	NOUN
dpc-5210	174	5	.	.	PUNCT
dpc-5210	175	1	2007;56(2):274	2007;56(2):274	NUM
dpc-5210	175	2	-	-	PUNCT
dpc-5210	175	3	278	278	NUM
dpc-5210	175	4	.	.	PUNCT
dpc-5210	176	1	doi:10.1016	doi:10.1016	PROPN
dpc-5210	176	2	/	/	SYM
dpc-5210	176	3	j	j	PROPN
dpc-5210	176	4	.jaad.2006.09.004	.jaad.2006.09.004	PROPN
dpc-5210	176	5	.	.	PUNCT
dpc-5210	177	1	pmid	pmid	NOUN
dpc-5210	177	2	:	:	PUNCT
dpc-5210	177	3	17224369	17224369	NUM
dpc-5210	177	4	.	.	PUNCT
dpc-5210	178	1	14	14	NUM
dpc-5210	178	2	.	.	PUNCT
dpc-5210	179	1	seneschal	seneschal	PROPN
dpc-5210	179	2	j	j	PROPN
dpc-5210	179	3	,	,	PUNCT
dpc-5210	179	4	duplaine	duplaine	ADJ
dpc-5210	179	5	a	a	PRON
dpc-5210	179	6	,	,	PUNCT
dpc-5210	179	7	maillard	maillard	ADJ
dpc-5210	179	8	h	h	NOUN
dpc-5210	179	9	,	,	PUNCT
dpc-5210	179	10	et	et	PROPN
dpc-5210	179	11	al	al	PROPN
dpc-5210	179	12	.	.	PROPN
dpc-5210	179	13	efficacy	efficacy	NOUN
dpc-5210	179	14	and	and	CCONJ
dpc-5210	179	15	safety	safety	NOUN
dpc-5210	179	16	of	of	ADP
dpc-5210	179	17	tacrolimus	tacrolimus	NOUN
dpc-5210	179	18	0.1	0.1	NUM
dpc-5210	179	19	%	%	NOUN
dpc-5210	179	20	for	for	ADP
dpc-5210	179	21	the	the	DET
dpc-5210	179	22	treatment	treatment	NOUN
dpc-5210	179	23	of	of	ADP
dpc-5210	179	24	facial	facial	ADJ
dpc-5210	179	25	vitiligo	vitiligo	NOUN
dpc-5210	179	26	:	:	PUNCT
dpc-5210	179	27	a	a	DET
dpc-5210	179	28	multicenter	multicenter	NOUN
dpc-5210	179	29	randomized	randomize	VERB
dpc-5210	179	30	,	,	PUNCT
dpc-5210	179	31	double	double	ADJ
dpc-5210	179	32	-	-	PUNCT
dpc-5210	179	33	blinded	blind	VERB
dpc-5210	179	34	,	,	PUNCT
dpc-5210	179	35	vehicle	vehicle	NOUN
dpc-5210	179	36	-	-	PUNCT
dpc-5210	179	37	controlled	control	VERB
dpc-5210	179	38	study	study	NOUN
dpc-5210	179	39	.	.	PUNCT
dpc-5210	180	1	j	j	PROPN
dpc-5210	180	2	invest	invest	VERB
dpc-5210	180	3	dermatol	dermatol	NOUN
dpc-5210	180	4	.	.	PUNCT
dpc-5210	181	1	2021;141(7):1728	2021;141(7):1728	NUM
dpc-5210	181	2	-	-	SYM
dpc-5210	181	3	1734	1734	NUM
dpc-5210	181	4	.	.	PUNCT
dpc-5210	182	1	doi:10.1016	doi:10.1016	PROPN
dpc-5210	182	2	/	/	SYM
dpc-5210	182	3	j	j	PROPN
dpc-5210	182	4	.jid.2020.12.028	.jid.2020.12.028	PUNCT
dpc-5210	182	5	.	.	PUNCT
dpc-5210	183	1	pmid	pmid	NOUN
dpc-5210	183	2	:	:	PUNCT
dpc-5210	183	3	33549606	33549606	NUM
dpc-5210	183	4	.	.	PUNCT